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Abstract 
Introduction: Brain-derived neurotrophic factor (BDNF) facilitates neuronal 
differentiation by activation of the TrkB receptor-tyrosine-kinase. BDNF/TrkB also 
modulates the activity of the excitatory N-methyl-D-aspartate neurotransmitter receptor 
(NMDAR), thereby also regulating neural plasticity and LTP/LTD, two forms of synaptic 
plasticity that contribute to the storage of information inside the brain. How TrkB cross-
talks to modulate NMDAR function is not known, although our working model involves 
the RasGrf1 signaling molecule, a nucleotide exchange factor for Ras/Rac-GTPases, 
which interacts with both receptors. In response to TrkB activation, Ras-Grf1 is tyrosine 
phosphorylated and mediates neurite outgrowth in PC12 cells. RasGrf1 also binds 
constitutively to the NMDAR to stimulate long-term-depression (LTD) in primary 
neurons. We hypothesize that TrkB activation of Ras-Grf1 will increase neuronal 
outgrowth in TrkB expressing PC12 derived cells (TrkB-B5) and BDNF will uncouple 
RasGrf1 from the NMDAR thereby facilitating a decrease in LTD and an increase in 
long-term-potentiation (LTP) in primary neurons.  
Method: PC12 (TrkB-B5) cells were transfected with appropriate plasmids, 
treated with BDNF (1ng/ml) and the percentage of neurite outgrowth was determined. 
Brain tissue slices from P30 mice were stimulated with either BDNF (100 ng/ml), 
NMDA (100 µM) or co-stimulated with both. Slices were then lysed and the protein 
interactions were assayed by immunoprecipitation and western blotting. 
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Results: We found that RasGrf1 expression significantly (P-value <0.05) 
increases neurite outgrowth in cell culture, in response to BDNF, which was dependent 
on the activation of both Ras and Rac. Although Tyr1048 and Tyr1062 appeared to be 
crucial sites of tyrosine phosphorylation on RasGrf1 for neurotrophin mediated neurite 
outgrowth in cell culture, tyrosine phosphorylation of RasGrf1 could not be detected in 
neural tissue slices in response to BDNF. Furthermore, we found a direct interaction 
between RasGrf1 and TrkB receptor in response to BDNF treatment in slice cultures.  In 
addition, BDNF stimulated the tyrosine phosphorylation of the NR2B subunit of the 
NMDA receptor at residue Tyr1472, which facilitates receptor retention at the cell surface, 
and also stimulated a dissociation of RasGrf1 from the NMDA receptor. 
Conclusion: My results strongly suggest that BDNF stimulation changes 
NMDAR signaling via TrkB activation and that this is mediated by RasGrf1. Future 
studies using RasGrf1 knockout mice will further address BDNF dependent changes in 
the activation of individual signalling molecules, and hippocampal culture studies from 
wild-type/RasGrf1 knock-out mice will address whether changes in BDNF-induced 
neuronal dendritic growth and spine formation are dependent on RasGrf1. 
 
Keywords: RasGrf1, NMDA receptor, TrkB, NR2B subunit, neurotrophins, neurite 
outgrowth, BDNF, NMDA, Ras, Rac, LTP, LTD, synaptic plasticity. 
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Chapter 1                
Cross-talk between Trk and NMDA receptors    
1.1 Neurotrophins and the receptors termed tropomyosin-related kinase (Trk) 
Neurotrophins, including nerve growth factor (NGF), brain-derived neurotrophic 
factor (BDNF), neurotrophin 3 (NT3) and neurotrophin 4/5 (NT 4/5), belong to a family 
of closely related growth factors (Meakin, 2000; Reichardt, 2006). Structurally, these 
proteins are homodimers with molecular weights of ~26 kDa and consist of 118-129 
amino acid subunits (McDonald et al., 1991; Robinson et al., 1995; Butte et al., 1998). 
They are derived from a precursor protein so called pre-proneurotrophin, which consists 
of about 250 residues with a signal sequence and a prodomain followed by the mature 
neurotrophin sequence (Lessmann and Brigadski, 2009).  
NGF was discovered in the 1950s as an essential growth factor in the developing 
nervous system (Levi-Montalcini, 1987; Shooter, 2001) while BDNF, as the second 
neurotrophin to be identified, was originally purified from brain lysates and was found to 
have high amino acid sequence homology to NGF (Barde et al., 1982). Subsequently, 
other members of the neurotrophin family were isolated using RT-PCR techniques and 
primer sequences conserved between NGF and BDNF (Barde et al., 1982; Berkemeier et 
al., 1991). The neurotrophins exert their biological activity by binding to and activating a 
low affinity receptor termed, p75, and one or more members of the high affinity 
tropomyosin-related kinase (Trk) family of receptors. trkA was originally identified as a 
transforming oncogene from a human colon tumor as a rearrangement between a gene 
encoding an intracellular tyrosine kinase domain with an extracellular sequence from a 
non-muscle tropomyosin gene and was so called the tropomyosin-related kinase (trk). 
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Subsequently, trkB and trkC were discovered based on high sequence homology to trkA 
(Martin-Zanca et al., 1986; Klein et al., 1989).  
Structurally, Trk receptors contain two cysteine clusters, with three leucine-rich 
motifs in between, followed by two immunoglobulin-like domains in the extracellular 
region (Figure 1.1), a transmembrane region and an intracellular tyrosine kinase domain 
with 5 effective tyrosine residues. All reigons in the extracellular domains are contributed 
directly or indirectly in ligand-Trk binding although the immunoglobulin-like domains 
are the major interfaces in this precess. Besides, from an evolutionary perspective, Trk 
receptors (A, B and C) are highly conserved in both intracellular and extracellular 
domains among vertebrates (Benito-Gutierrez et al., 2006). In comparison, the p75 
receptor contains four cysteine-rich domains on the extracellular side as well as an 
intracellular death domain similar to that first described in tumor necrosis factor receptor 
(NTR) family members (Liepinsh et al., 1997; Chao and Hempstead, 1995; Huang and 
Reichardt., 2003; He and Garcia, 2004). Although p75 shares no sequence homology to 
Trk, the three-dimensional structure of its extracellular domain has been shown to form a 
binding site for the NGF dimer involving all four cysteine-rich repeats (He and Garcia, 
2004).     
The two different receptor classes of p75 and Trk have distinct preferences for the 
two forms of ligands; namely, pro-neurotrophins for p75NTR and mature neurotrophins for 
Trk receptors. In this respect, NGF binds TrkA, BDNF binds TrkB, NT-3 binds TrkC, 
and NT-4/5 binds both TrkB and TrkC. In addition to binding Trk receptors with high 
affinity (nM), all mature neurotrophins can bind with low affinity to p75 (µM). In 
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contrast, all pro-neurotrophins bind with high affinity to p75 (Figure 1.1) (Meakin, 2000; 
Reichardt, 2006; Frade and Barde, 1998).  
A general consequence of Trk receptor tyrosine kinase activation includes cell 
survival, neuronal growth and differentiation, as well as a specific role of TrkB in 
modulating synaptic plasticity in the central nervous system (Meakin, 2000; Reichardt, 
2006). In contrast, neurotrophin-mediated activation of p75NTR initiates signaling 
pathways leading to apoptosis (Lee et al., 2001; Song et al., 2002). However, recent 
studies have also shown some roles for Trk receptor signaling outside the nervous system 
including cardiac development, neovascularization and in the immune system (Donovan 
et al., 2000; Lin et al., 2000; Coppola et al., 2004; Kermani et al., 2005).   
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Figure 1.1. A schematic diagram of the neurotrophin receptor subtypes p75NTR and 
the receptor tyrosine kinase family of Trk receptors. Tropomyosin related kinases 
(Trk), including TrkA, B and C, are receptors for a family of growth factors including 
NGF which binds TrkA, BDNF and NT 4/5 which bind TrkB and NT3 which binds 
TrkC. Moreover, all neurotrophins bind p75 receptor with low affinity while all pro-
neurotrophins bind p75 with high affinity. Structurally, Trks have an extracellular region 
containing 2 cysteine-rich clusters (CC), leucine rich motifs (LRM) and immunoglobin-
like domains (Ig-D), and also an intracellular tyrosine kinase domain (KD) with 5 
tyrosine residues which can be auto-phosphorylated upon binding to the ligand and 
dimerization. These phosphorylation sites on TrkB include Tyr516 Tyr702, Tyr706, Tyr707 
and Tyr817 which are equivalent to Tyr499, Tyr679, Tyr683, Tyr684, and Tyr794 on TrkA. In 
addition, the p75NTR consists of four cysteine rich motifs (CRM) as wells as an 
intracellular death domain (DD). 
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1.2 Neurotrophins and Trk expression 
The expression pattern and localization of neurotrophins and their receptors varies 
depending on regions within the peripheral and central nervous systems. Table 1 
summarizes the pattern of neurotrophins and their receptor expression in different tissues 
of the nervous system (Korsching and Thoenen, 1983; Heumann et al., 1984; Davies et 
al., 1987; Heumann et al., 1987; Korsching, 1993; Eide et al., 1993; Avila et al., 1993; 
Ernfors et al., 1992; Knusel et al., 1991; Hyman et al., 1991; Ernfors et al., 1990). Note 
that generally in the hippocampus, TrkB receptors are localized in the axons, nerve 
terminals and dendritic spines of glutamatergic neurons (Drake et al., 1999). In particular, 
although TrkA is not expressed inside the hippocampus, NGF is expressed and secreted 
in the hippocampus to activate TrkA receptors in the termini of cholinergic neurons 
projecting from the basal forebrain (Meakin, 2000). Once action potentials are 
propagated at the nerve terminal, which results in the opening of voltage-gated channels 
on the presynaptic membrane and fusion machinery are activated , secretory vesicles of 
neurotrasmitter are released in either regulative or constitutive pathways. NGF is secreted 
predominately in a constitutive way specifically in hippocampal neurons while BDNF 
transcription and secretion are regulated in an activity-dependent manner (Mowla et al., 
1999; Farhadi et al., 2000; Lessmann et al., 2003; Lu, 2003). Neuronal activity 
remarkably increases BDNF expression in hippocampal neurons, and its release in the 
presynaptic membrane in response to an increase in calcium concentration (Patterson et 
al., 1992; Dragunow et al., 1993; Kuczewski et al., 2009). Activity-dependent secretion 
of BDNF appears to be important for normal hippocampal function as a mutation in 
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BDNF prodomain (Val 66 to Met) impairs BDNF trafficking and increases the 
susceptibility to neuropsychiatric disorders (Egan et al., 2003; Hariri et al., 2003). 
 
Table 1.1. Neurotrophin and Trk expression pattern in various areas of the nervous 
system.  
Tissues NGF TrkA BDNF TrkB NT3 TrkC 
Dorsal Root Ganglia  
      (DRG) 
+ + + +  + 
Sympathetic Ganglia  +     
Motor Neurons   ++ +   
Cerebral Cortex   + + + + 
Striatum  +     
Hippocampus +  + + + + 
Cholinergic Neurons  +     
GABAergic Neurons    +   
Dopaminergic Neurons    +   
Cerebellum    + + + 
Hypothalamus    +  + 
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1.3 Neurotrophin-mediated Trk activation 
Neurotrophins initiate their signal transduction through activation of their 
receptors, Trk or p75NTR. In case for Trk, once neurotrophins bind, the receptor tyrosine 
kinase is dimerized, which results in tyrosine-autophosphorylation in the intracellular 
kinase domain. The major sites of phosphorylation on rat TrkA include tyrosine residues 
499, 679, 683, 684, and 794. While tyrosine residues 679, 683 and 684 in the kinase 
domain remain in an open conformation in the inactive receptor, these phosphorylation 
sites form a stable activation loop by conformational change upon phosphorylation which 
subsequently, with further phosphorylation of tyrosine 499 and 794, serve as docking 
sites for intermediate signaling (adaptor) molecules leading to activation of distinct 
pathways and diverse physiological responses (Hanks et al., 1988; Ibanez et al., 1993; 
Heldin, 1995; Hubbard, 1997).  
One such adaptor molecule is the Src homology 2 (SH2)-domain containing 
protein Shc (ShcA, B and C) which binds to phosphorylated tyrosine at position Y499 by 
its phosphotyrosine binding (PTB) domain, and another adaptor molecule is Fibroblast 
growth factor Receptor Substrate 2 (FRS2) which competes with Shc to bind at this site 
(Liu and Meakin, 2002; Stephens et al., 1994; Meakin et al., 1999). Adaptor proteins are 
intermediate signaling molecules that mediate specific protein-protein interactions 
without intrinsic enzymatic activity. In addition, Pleckstrin homology (PH) or Src 
homology 2 (SH2) domain containing proteins also bind to other tyrosine sites on Trk 
and activate Trk-mediated signaling pathways. Another major signaling protein is 
phospholipase Cγ-1 (PLCγ-1) which binds to phosphorylated tyrosine at position Y794, 
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activation of which results in an increase in intracellular Ca2+ concentration (Minichiello, 
2009). 
Through these adaptor molecules, Trk receptors are able to activate three major 
signaling pathways (Figure 1.2) including the Ras-mitogen activated protein kinase (Ras-
MAPK) pathway, the phosphotidylinositol-3 kinase (PI3K)-Akt pathway, and the PLCγ-1 
pathway (Barbacid, 1994; Huang and Reichardt, 2003; Reichardt, 2006; Minichiello, 
2009).  
In the Ras-MAPK pathway, phosphorylated Trk at position 516 of TrkB 
(Kavanaugh and Williams, 1994), or analogous sites on TrkA and TrkC, mediate Shc 
activation and recruitment of the adaptor protein Grb2 (growth factor receptor-bound 
protein 2) and the SOS (son of sevenless) guanine nucleotide exchange factor, leading to 
activation of Ras-GTPase and the kinase c-Raf-1 (English and Sweatt, 1997; Reichardt, 
2006; Minichiello, 2009). Subsequently, associated Mek1/2 kinases are activated 
resulting in a transient activation of Erk1/2 MAP kinases which underlie proliferation and 
cell cycle progression (English and Sweatt, 1997; Reichardt, 2006; Minichiello, 2009). In 
contrast, Trk-mediated FRS2 activation recruits the adaptor protein Crk, the C3G 
nucleotide exchange factor leading to activation of Rap-1 GTPase, and the kinase b-Raf 
which subsequently results in prolonged activation of Erk1/2 MAP kinase underling cell 
cycle arrest and differentiation (Kao et al., 2001; Wu et al., 2001; Egan et al., 1993). 
Through the PI3K-Akt pathway, phosphotidylinositol-3 kinase is activated in 
either Ras-independent or Ras-dependent pathways.  In the Ras-independent pathway, the 
Gab1 (GRB-associated binder-1 adapter) is recruited to TrkB indirectly through Grb2, 
and in turn binds to PI3K. Upon this association, PI3K is able to convert 
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phosphatidylinositol (PtdIns) into phosphatidylinositol 3-phosphate (PI3P), and in the 
presence of PI3P, the 3-phosphatidylinositide-dependent protein kinases (PDPK-1&2) are 
able to activate the Akt protein kinase (or protein kinase B). Akt can prevent cell death or 
apoptosis by phosphorylation (inactivation) of pro-apoptotic proteins and activating 
growth promoting substrates that underlie cell survival (Yuan and Yankner, 2000; Brunet 
et al., 1999; Yuan et al., 2003; Sini et al., 2004; Huang and Reichardt., 2003; Minichiello, 
2009). 
In contrast, in the phospholipase Cγ-1 pathway, Trk-mediated activation of PLCγ-
1 hydrolyses phosphotidylinositol 4,5-biphosphate (PtdIns 4,5-P2 ) to generate inositol 
1,4,5-triphosphate (Ins 1,4,5-P3) and diacylglycerol (DAG). InsP3 promotes the release of 
Ca2+ from the endoplasmic reticulum, while DAG stimulates protein kinase C (PKC) 
activation at the cell surface (Zirrgiebel et al., 1995; Roback et al., 1995; Patapoutian and 
Reichardt., 2001; Huang and Reichardt., 2003; Minichiello, 2009). Increases in Ca2+ 
levels result in the activation of a wide variety of signaling proteins underling synaptic 
plasticity including protein kinase A (PKA) and calcium/calmodulin-dependent kinases 
(CaMKII, CaMKK and CaMKIV) (Huang and Reichardt., 2003; Minichiello, 2009). 
Collectively, it appears that by three different major pathways mentioned above, Trk 
receptors are able to finally activate four different protein kinases upstream of MAP-
kinases, including PKA (cAMP-dependent protein kinases), PKB (PI3K-dependent 
protein kinases), PKC (DAG-dependent protein kinases), and Ca2+-dependent protein 
kinases. 
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Figure 1.2. A schematic diagram of three major Trk-mediated signaling pathways. 
1) In Ras-Erk pathway (white color), tyrosine phosphorylation of Trk at position 516 
(Y499 on TrkA) activates the Shc adaptor protein which in turn recruit Sos and Grb2, 
leading to activation of Ras and transient activation of Erk1/2 underlying cell 
proliferation. Moreover, FRS2 (blue color) competes with Shc to couple Trk to Rap-1 
which leads to sustained activation of Erk1/2 underlying neural differentiation. 2). PI3K 
pathway (grey color) acts indirectly through Grb2 downstream of TrkB to recruit Gab1 or 
directly through Ras. In response to this association, PI3K activates Akt leading to cell 
survival. 3) In the PLCγ-1 pathway (yellow color), phospholipase Cγ-1 binds to 
phosphorylated tyrosine at position 817 (Y794 on TrkA) resulting in an increase in 
intracellular Ca2+ concentration, which in turn results in the activation of a wide variety of 
signaling proteins underling synaptic plasticity. RasGrf1 
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1.4 Trk and clinical disorders 
Several isoforms of TrkA, B and C have been reported in different studies, some 
of which are associated with clinical disorders either due to changes in the expression 
level or a mutation in both receptors and neurotrophins. For instance, a decrease in BDNF 
levels were reported in the postmortem brain of Parkinson’s patients (Nagatsu and 
Sawada, 2007), and in the limbic structure of patients with depression, epilepsy and 
bipolar disorder (Kozisek et al., 2008; Ren and Dubner, 2007). These group of patients 
exhibit atrophy in the hippocampus and prefrontal cortex in which treatment with anti-
depressants increases BDNF expression and its function, resulting in limitation of the 
side effects and atrophy (Monteggia et al., 2007). A mutation in BDNF (V66M) increases 
the susceptibility of patients to neuropsychiatric disorders with memory impairment due 
to deficits in BDNF transport and decreases in BDNF secretion levels (Chen et al., 2006; 
Bath and Lee, 2006; Egan et al., 2003). As such, BDNF has been suggested as a potential 
therapeutic agent for neurogolical and psychiatric disorders such as Alzheimer’s, 
Parkinson’s, Huntington’s, Stroke, Spinal cord injury, and also to regulate metabolic 
disorders such as Obesity and Diabetes due to a high expression of BDNF in the 
ventromedial hypothalamus which regulates appetite and food intake (Nagahara and 
Tuszynski, 2011). In addition, TrkB has been suggested as a therapeutic target for several 
types of human cancers such as neuroblastoma, prostate and pancreatic adenocarcinomas, 
and liver metastases (Desmet and Peeper, 2006). Recent studies have also reported a 
correlation between Alzheimer’s disease and impairment in NGF transport from the 
hippocampus and neocortex to cholinergic neurons of the basal forebrain (Schindowski et 
al., 2008) as well as mutations in the trkB gene (Vepsalainen et al., 2005).   
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Moreover, alternative splicing of TrkA generates an isoform with an additional 6 
amino acid residues in the proximal region of the extracellular domain. This isoform 
gains the additional ability to bind NT3 and being predominantly expressed in neuronal 
cells while TrkA lacking this additional amino acid fragment binds specifically to NGF 
(Barker et al., 1993). Truncated TrkB and TrkC isoforms, lacking a functional motif in 
the intracellular domain, have been also described as being able to inhibit full length Trk 
perhaps by forming non-functional heterodimers with full length subunits (Middlemas et 
al., 1991; Tsoulfas et al., 1993; Eide et al., 1996; Palko et al., 1999; Rose et al., 2003). A 
dominant mutation on TrkB in an activation loop tyrosine (Y722C) has also been observed 
in patients with severe early onset hyperphagia (excessive appetite) as well as being 
associated with a severe impairment in learning and memory (Yeo et al., 2004). 
Moreover, an alternative splicing isoform of TrkC containing additional 14-39 amino 
acids residues in the intracellular kinase domain has also been reported to reduce the 
ability of the receptor to activate downstream signaling adaptors such as Shc and PLCγ 
(Reichardt, 2006; Barbacid, 1994). Trk receptors have also been shown to co-ordinate 
and co-operate with other receptors including G protein-coupled receptors (GPCR) 
(Weise et al., 2007; Lee and Chao, 2001; Lee et al., 2002a&b; Rajagopal et al., 2004), 
AMPA receptors (Wu et al., 2004; Caldeira et al., 2007) as well as NMDA receptors 
(Kang and Schuman, 2000; Amaral and Pozzo-Miller, 2007; Wu et al., 2004; Xu et al., 
2006).   
1.5 Neurotrophins and Trk regulation 
Several mechanisms regulate neurotrophins and Trk expression, secretion and 
their function. Neurotrophins are regulated by membrane insertion, through intra and 
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extracellular trafficking, and by changes in protease activity (Thoenen and Barde, 1980). 
Since some proteases convert pro-neurotrophins to mature neurotrophins, and pro-
neurotrophins have high affinity binding to p75NTR to activate signaling pathways leading 
to apoptosis (Lee et al., 2001), low protease activity can regulate mature neurotrophin 
levels. In fact, it has been shown that mature BDNF facilitates hippocampal long term 
potentiation (LTP) through TrkB while pro-BDNF promotes long term depression (LTD) 
through p75NTR (Patterson et al., 1996; Minichiello et al., 2002), and several studies 
suggest that enhanced pro-neurotrophin levels following brain injury may increase 
neuronal loss due to binding and activation of p75NTR (Fahnestock et al., 2001; 
Harrington et al., 2004; Pedraza et al., 2005).  
Trk is localized intracellularly inside membranous vesicles in the absence of 
signals. However, signals such as cAMP, electrical activity or calcium increase the 
insertion of Trk into the plasma membrane (Barker et al., 2002; Heerssen and Segal, 
2002). The ligand-activated Trk complex is internalized through clathrin coated pits 
(Valdez et al., 2005) while its extracellular part is bound to ligand and intracellular side 
associated with a number of signaling molecules such as PLCγ, PI3K or Ras-MAP kinase 
(Grimes et al., 1996; Howe et al., 2001). These endosomal vesicles are then transported retrogradely 
to the cell soma where they activate other Trk-dependent substrates (Wu et al., 2001; 
York et al., 2000; Delcroix et al., 2003; Huang et al., 1999; Huang and Reichardt, 2003). 
 
 
 
1.6 NMDA receptor 
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The N-methyl-D-aspartate (NMDA) receptor is an ionotropic channel (Figure 
1.3A) that upon activation by glutamate in vivo or NMDA stimulation in vitro, allows the 
flow of Na+, and to a lesser extent Ca2+, into the cell as well as K+ out of the cell.  
It is a heterotetrameric complex predominately made up of two obligatory NR1 
subunits which bind to glycine and two modulatory NR2 subunits which bind to 
glutamate and control the electrophysiological properties of the NMDA receptor. 
Recently, growing evidence suggests that there are also glycine-binding NR3 subunits in 
the structure of NMDA receptors. NR1 subunits consist of eight different subtypes 
alternatively spliced from a single gene. NR2 subunits consist of four different A-D 
subtypes while NR3 subunits consist of two different A and B subtypes and together with 
NR2, they are encoded by six separate genes (Kutsuwada et al., 1992; Monyer et al., 
1992; Paoletti, and Neyton, 2007).  
 While NMDA receptors contribute to both LTP and LTD, several studies suggest 
that NR2A subunits of the NMDA receptor promote LTP whereas NR2B subunits 
contribute to LTD (Li et al, 2006; Kollen et al., 2008; Liu et al., 2004; Massey et al., 
2004). 
The cell surface localization of the NMDA receptor is regulated through clathrin-
mediated endocytosis in which the 1472YEKL internalization motif on the NR2B subunit 
serves a pivotal role in this process. Phosphorylation of tyrosine 1472 (Tyr1472) of the 
YEKL motif by Src family kinases uncouples the NMDA receptor from clathrin-
mediated internalization and increases the retention and activity of the receptor at the cell 
surface (Nakazawa et al., 2001; Prybylowski et al., 2005).  
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Figure 1.3. A schematic diagram of the NMDA receptor and physiological events 
during neurite outgrowth, Long Term Potentiation and Long Term Depression. A) 
The NMDA receptor is an ionotropic channel that upon activation allows the flow of Na+ 
and small amounts of Ca2+ ions into the cell and K+ out of the cell. It is a heterotetrameric 
complex made up of two obligatory NR1 and two modulatory NR2 subunits. It has been 
shown that RasGrf1 binds to the NR2B subunit of NMDA receptor (Krapivinsky et al., 
2003). B) The major physiological events that occur during LTP and LTD. In LTP, there 
is an increase in the postsynaptic transmission of ions such as Na+, K+ and Ca2+ rather 
than weakening of postsynaptic transmission during LTD. LTP can be induced with a 
high-frequency stimulation through receptors present on the surface of the postsynaptic 
membrane, rather than a low frequency stimulation that stimulates LTD. LTP is an 
outcome of an increase in the activity of the receptors either by increasing the number of 
receptors on the postsynaptic cell surface or by increasing presynaptic factors, whereas 
LTD is an outcome of a decrease in the activity of these same receptors. Ca2+ entry above 
threshold is associated with LTP and low Ca2+influx leads to LTD.  
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1.7 Long Term Potentiation (LTP) and long Term Depression (LTD) 
LTP and LTD are two forms of synaptic plasticity that contribute to the storage of 
information during different types of learning and memory inside the brain, particularly 
in the hippocampus area of the brain (Table 2) (Lau and Zukin, 2007; Lu et al., 2008; 
Lynch, 2004). LTP lasts for hours up until days and involves gene expression and new 
protein synthesis, and it is in contrast to Short Term Potentiation (STP) which lasts 
seconds up until minutes involving the interaction between existing proteins and is 
independent of gene expression and protein synthesis (Figure 1.3B) (Lynch, 2004; Lu et 
al., 2008; Minichiello, 2009).  
LTP can be induced with high-frequency stimulation of receptors present on the 
surface of the postsynaptic membrane (Figure 1.3B), which results in an increase in the 
postsynaptic transmission of ions such as Na+, K+ and Ca2+. In contrast, LTD is an 
outcome of low frequency stimulation, a decrease in the activity of the NMDA receptor, 
and weakening of postsynaptic transmission. The outcome of both LTP and LTD are 
changes in intracellular Ca2+ concentrations, as Ca2+ entry above a threshold is associated 
with LTP and a modest increase in Ca2+ level leads to LTD (Lu et al., 2008; Minichiello, 
2009). LTP represents improved communication between two neurons and is mediated by 
the excitatory neurotransmitter glutamate in vivo or NMDA in in vitro studies.  
LTP is observed not only in the hippocampus, but also in other neural structures 
including the cerebral cortex, cerebellum or amygdala (Bauer et al., 2002; Nakazawa et 
al., 2006; Minichiello, 2009). In general, LTP can be dependent or independent on 
NMDA receptors. However, the NMDA receptor-dependent is the most widely studied 
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model of LTP in the CA3-CA1 (Cornu Ammonis) area of the hippocampus (Lisman, 
2003).  
Table 1.2. Different types of learning and memory in various areas of the brain.  
Types of learning/memory Brain area involved 
Spatial memory Hippocampus, Parahippocampus, Subiculum, Cortex, 
Temporal cortex, Area 47, Posterior parietal cortex 
Emotional memory Amygdala 
Recognition memory Hippocampus, Temporal lobe 
Working memory Hippocampus, Prefrontal cortex 
Motor skills Striatum, Cerebellum 
Sensory (visual, auditory, 
tactile) 
Various cortical area 
Classical conditioning Cerebellum  
Habituation Basal ganglia 
 
1.8 BDNF-mediated TrkB activation and neural plasticity   
The TrkB receptor is expressed widely inside the brain including the cortex and 
hippocampus and in addition to its well known effects on neuronal outgrowth and 
differentiation, TrkB activation is crucial in various aspect of synaptic plasticity in the 
entire brain including the cortex, hippocampus, cerebellum and amygdala (Carvalho et 
al., 2008; Lu et al., 2008). TrkB receptors have been found on both presynaptic and 
postsynaptic membranes of the nerve terminal and dendritic spines, and BDNF-mediated 
TrkB receptors have been suggested to modulate dendritic branches and spine formation 
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during neural plasticity within cortical, cerebellar and hippocampal synapses (Amaral et 
al., 2007; Minichiello, 2009). 
BDNF plays a role in synaptic transmission on the postsynaptic membrane in 
addition to its well known effects on neuronal outgrowth and differentiation (Tyler et al., 
2002). Although the mechanism by which BDNF regulates NMDA receptor-mediated 
neural plasticity is poorly understood, it appears that by indirectly modulating NMDA 
receptor activity, BDNF helps to regulate two important processes of learning and 
memory, namely LTP and LTD (Xu et al., 2006; Kang et al., 1997; Akaneya et al., 1997; 
Lessmann and Heumann, 1998; Levine et al., 1998; Levine and Kolb, 2000; Li et al., 
1998). The evidence for a role of BDNF-mediated TrkB activation in LTP comes from 
the fact that any deletion in the bdnf or trkB genes, or in vivo blocking of BDNF binding 
to TrkB and pre-treating hippocampal slices with anti-TrkB antiserum, can either impair 
or significantly reduce the induction of LTP (Minichiello, 2009). Further studies have 
also suggested that NMDA receptor activity can increase BDNF expression leading to 
further TrkB-mediated regulation of NMDA receptors during synaptic plasticity 
(Caldeira et al., 2007).  
BDNF activates TrkB receptors, which upon activation in turn modulates the 
tyrosine phosphorylation status of the NR2B subunits of NMDA receptors and increases 
the retention of these receptors on the postsynaptic cell surface (Nakazawa et al., 2001; 
Prybylowski et al., 2005). As a result of prolonged surface retention of the NMDA 
receptor, and the ability to respond to L-glutamate, the intracellular calcium levels 
increase in the postsynaptic neuron (Minichiello, 2009; Lin et al., 1998; Levine et al., 
1998; Levine and Kolb, 2000). Increases in Ca2+ influx in postsynaptic neurons finally 
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influences the physiological properties and trafficking of the postsynaptic glutamate 
receptors such as the NMDA receptor through phosphorylation/ dephosphorylation, and 
results in the activation of a number of signaling molecules including PKC, PKA and the 
calcium-sensitive calmodulin-activated kinases (CaMKI, II and IV) (Ghosh and 
Greenberg, 1995; West et al., 2001; Minichiello, 2009), leading to initiation of signaling 
cascades that underlie neuronal growth, development and synaptic plasticity (Li et al., 
2006; Minichiello, 2009). 
Among these kinases, PKA and CaMK have been suggested to phosphorylate the 
alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) type of glutamate 
receptor that is involved primarily in the postsynaptic membrane depolarization and the 
maintenance of LTP, and also the NMDA receptor which is implicated in the induction or 
initiation of LTP (Lynch, 2004; Soderling and Derkach, 2000; Song and Huganir, 2002; 
Malenka and Bear, 2004). Furthermore, they activate a Ras-guanine nucleotide releasing 
factor termed RasGrf1 (Farnsworth et al., 1995) through either serine phosphorylation at 
residue 916 (S916) on RasGrf1 (Schmitt et al., 2005) or unknown sites of tyrosine-
phosphorylation by the non-receptor tyrosine kinases Src (Kiyono et al., 2000a) and Ack1 
(Kiyono et al., 2000b). 
1.9 RasGrf1 is a common substrate of both TrkB and NMDA receptors 
RasGrfs belong to a family of guanine nucleotide exchange factors (GEFs), other 
members of which include Sos (Simon et al., 1991; Ferrari et al., 1994) and C3G 
(Knudsen et al., 1994; Tanaka et al., 1994). RasGrf is present in two forms. One form is 
RasGrf1 (140 kDa with 1262 amino acids) which is highly expressed in the nervous 
system (Zippel et al., 1997). The other form is RasGrf2 (130 kDa with 1189 amino 
23 
 
acids), which shows a high degree of sequence homology (80%) to RasGrf1, and is 
expressed ubiquitously, but is also present within the mature brain (Fam et al., 1997; 
Anborgh et al., 1999).  
The expression pattern and localization of RasGrf1 has been extensively studied 
in the rat brain. The full length RasGrf1 protein is expressed in mature neurons of the rat 
brain and spinal cord, but not in glial cells. The hippocampus, amygdala, thalamus, 
hypothalamus, cortex, striatum, cerebellum, and retina are the major sites of full length 
RasGrf1 protein expression (Itier et al., 1998; Shou et al., 1992; Wei et al., 1993; Zippel 
et al., 1997; Fernandez-Medarde et al., 2009), and later sub-cellular fractionation studies 
have indicated the presence of RasGrf1 in post-synaptic densities and its localization in 
the dendrites and soma of neuronal cells (Zippel et al., 1997; Sturani et al., 1997). 
Outside the nervous system, RasGrf1 is also expressed in lower levels in pancreatic β-
cells suggesting that it might be involved in normal pancreas development, glucose 
haemostasis and Diabetes (Itier et al., 1998; Font de Mora et al., 2003; Hoffmann and 
Spengler, 2012).  
Mouse RasGrf1 was originally identified (Shou et al., 1992) as a homologue to 
CDC25 (cell division cycle 25), an activator of Ras-GTPase, in the yeast S. cerevisiae, 
and was initially so called CDC25Mm (Martegani et al., 1992; Wei et al., 1992). 
Subsequently, a 140 kDa RasGrf1 was isolated from Rat brain homologous to 
CDC25Mm (Gariboldi et al., 1994), and further study in the mouse brain led to isolation 
of other naturally occurring splice variants of RasGrf1 including a 58 kDa and 20 kDa 
truncated products (Ferrari et al., 1994; Arava et al., 1999; Feig, 2011). The 58 kDa 
isoform is expressed predominantely during embryogenesis while the full length 140kDa-
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RasGrf1 is expressed in the mature mouse brain (Ferrari et al., 1994). The small isoform 
of 20kDa has been identified predominantely in the mouse pancreas (Arava et al., 1999). 
Mouse RasGrf1 is located on chromosome 9 with 26 exons (de la Puente et al., 
2002) while RasGrf2 is located on the long arm of chromosome 13 with 24 exons. 
Human RasGrf1 is largely similar to mouse RasGrf1 with 82.7% sequence homology. An 
extra small fragment of full length hRasGrf1 with 1273 amino acids does not affect the 
function of any conserved domains (Fernandez-Medarde and Santos, 2011). RasGrf1 is 
an imprinted gene (preferentially from the paternal allele) which is expressed only after 
birth in the mouse, rat and human, and its transcription is mostly regulated through 
methylation and alternative splicing mechanisms (Plass et al., 1996; Kaneda et al., 2004; 
Fernandez-Medarde and Santos, 2011). 
Structurally, RasGrf1 is a large multi-domain protein that is recruited by a diverse 
range of signaling molecules (Figure 1.4). These domains include a pleckstrin homology 
(PH) domain in the amino-terminus, a coiled coil (CC) and ilimaquinone (IQ) motif, a 
Db1 homology domain (DH), a Ras exchange motif (REM), a cyclin destruction box 
(CDB) and a cell division cycle 25 (CDC25) domain in the C-terminus (Fernandez-
Medarde and Santos, 2011).  
Among these domains, the PH domain, which is necessary for RasGrf1 
localization in the plasma membrane (Buchsbaum et al., 1996), has been suggested being 
able to bind to phosphoinositides and other types of phospholipids in the membrane 
(Harlan et al., 1994; Lemmon and Ferguson, 2000; Varnai et al., 2002), also acts as 
putative phosphotyrosine binding (PTB) domain (Balla, 2005; Cowburn, 1997). RasGrf1 
can also bind to βγ subunits of G protein-coupled receptors via the PH1 domain (Touhara 
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et al., 1994; Shou et al., 1995; Mattingly and Macara, 1996; Zippel et al., 1996) and has 
also been shown to interact with Trk family receptor tyrosine kinases via their HIKE 
motifs (Robinson et al., 2005). Coiled coil domains play a role in protein-protein 
interactions in cooperation with PH1 and IQ domains (Buchsbaum et al., 1996), but no 
specific function has been reported for this domain.  
The IQ domain is capable of interacting with the protein calmodulin in a Ca2+-
independent manner. In response to calcium elevation, RasGrf1 is activated by binding of 
calcium/calmodulin to the IQ motif (Buchsbaum et al., 1996; Farnsworth et al., 1995). 
Moreover, it has been revealed that a point mutation in the IQ domain, which blocks 
calmodulin binding, can in fact prevent calcium-induced Ras activation (Buchsbaum et 
al., 1996). The DH domain binds the Rho family of GTPases, in particular Rac1, and 
promotes guanine nucleotide exchange activity toward Rac1 (Freshney et al., 1997; 
Kiyono et al., 1999; Innocenti et al., 1999). It has been suggested that DH domain might 
contribute to RasGrfs oligomerization (Anborgh et al., 1999), and in association with the 
adjacent PH2 domain, they can mediate interaction with other intracellular compartments 
such as microtubules, microtubule-binding proteins (Forlani et al., 2006; Baldassa et al., 
2007).  
The REM motif plays a role in stabilization of the core CDC25 domain and the 
CDB or PEST domain is a region between the REM and CDC25 domains which is rich in 
proline, glutamic acid, serine and threonine amino acids and constitutes a hypothetical 
target for proteolysis, an additional mechanism to regulate the cellular levels of RasGrf1 
protein (Rogers et al., 1986; Baouz, et al., 1997;; Gnesutta et al., 2001). Lastly, the 
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CDC25 domain facilitates the activation of the Ras-GTPase (Tian and Feig, 2001; Cen et 
al., 1993; Wei et al., 1994). 
A role for GEFs in general, and RasGrfs in particular, is to promote the exchange 
of GDP for GTP on small GTPase proteins such as Ras and Rac which act as molecular 
switches of active GTP-bound and inactive GDP-bound states (Tian et al., 2004; Katoh et 
al., 2000). Initially, a transient GEF-GTPase-GDP complex is formed by binding of GEF 
to GTPase-GDP which promotes a conformational change in the GTPase structure and 
release of GDP. Subsequently release of GDP results in formation of a stable GEF-
GTPase-GTP complex. Finally, the GEF is released and the activated GTPase can in turn 
activate various signaling cascades (Tian and Feig, 2001; Consonni et al., 2003). In 
contrast to GEFs, GTPase Activating Proteins (GAPs) have been suggested to inactivate 
Ras-GTPases by hydrolyzing GTP bound to GDP (Pamonsinlapatham et al., 2009). Small 
GTPase proteins serve pivotal roles in linking external messages from cell surface 
receptors to several downstream signaling cascades underlying a wide variety of cellular 
processes including cell cycle regulation, cytoskeletal reorganization, neurite outgrowth 
and differentiation (Crespo and Leon, 2000; Malumbres and Pellicer, 1998; Huang and 
Reichardt, 2003).  
Although several evidences have documented a correlation between RasGrfs 
action downstream of Trk (MacDonald et al., 1999; Robinson et al., 2005) or G-protein 
coupled receptors to the activation of Ras and Erk-MAP kinases (Baouz et al., 2001; 
Mattingly and Macara, 1996; Shou et al., 1995; Zippel et al., 1996) as well as Rac 
(Kiyono et al., 1999), RasGrfs have also been suggested as a missing link in the 
regulation of synaptic plasticity (Brambilla et al., 1997). They act as a specific calcium 
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sensor to transmit signals from the NMDA receptor to the activation of appropriate 
GTPases and the induction of LTP or LTD (Li et al., 2006). It has been shown that 
RasGrf1 interacts directly with the NR2B subunit of the NMDA receptor (Krapivinsky et 
al., 2003), through which RasGrf1 stimulates p38/MAP kinase activation leading to an 
increase in LTD. In contrast, RasGrf2 interacts with the NR2A subunit of the NMDA 
receptor and activates Erk/MAP kinase leading to an increase in LTP (Li et al., 2006). 
Both interactions are observed in a developmental-dependent manner, in particular after 
postnatal day 20 to 25 in the mouse (Li et al., 2006). It has further been shown that 
RasGrf1 promotes p38 activation by Rac in vitro while RasGrf2 activates Erk-MAP 
kinase by targeting Ras-GTPases (Buchsbaum et al., 2002; Tian et al., 2004).  
Further evidence supporting a role for RasGrf1 in the regulation of synaptic 
plasticity, growth and development comes from studies in RasGrf1 knockout mice 
(Brambilla et al., 1997; Giese et al., 2001; Itier et al., 1998; Font de Mora et al., 2003; 
Clapcott et al., 2003; d'Isa et al., 2011). Although RasGrf1 knockout mice models 
represent various phenotypes depending on which part of the RasGrf1gene is being 
targeted, which isoforms are being blocked, and which region of brain inside the central 
nervous system is being involved (Feig, 2011), it appears that full length RasGrf1 
knockout (-/-) results in a severe deficit in amygdala-dependent synaptic plasticity 
(Brambilla et al., 1997), as well as impairments in hippocampal-dependent plasticity 
observed as failures to perform hippocampal-dependent behavioral tests such as the 
Morris water maze, contextual discrimination and social transmission of food preferences 
(Giese et al., 2001).  
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     1141 skqtkslldk lqklvssdgr fknlreslrn cdppcvpylg myltdlvfie egtpnytedg 
     1201 lvnfskmrmi shiireirqf qqttykidpq pkviqyllde sfmldeesly esslliepkl 
     1261 pt 
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Figure 1.4. A Schematic diagram of the RasGrf1 protein. Mouse RasGrf1, a 140kDa 
protein with 1262 amino acids consist of several binding domains including a binding 
domain to interact with TrkB (PH1; pleckstrin domain), and binding area with NR2B 
subunit (amino acids 714-913), coiled-coil motif (CC), ilimaquinone (IQ) to bind 
calmodulin, Db1 homology domain (DH) to activate Rac, the second pleckstrin domain 
(PH2), Ras exchange motif (REM), cycline destruction box (CDB), and catalytic domain 
(CDC25) to activate Ras. S916 is the site for RasGrf1-phosphorylation by PKA, the W1056 
on RasGrf1 has been suggested as binding site for GDP-Ras, and the sequences area of 
amino acids 714-913 have been described as neural domain (ND) which binds NR2B 
subunit of NMDA receptor. The lower panel represents an amino acids sequence of 
mouse RasGrf1 with S916 shown in red color. 
 
 
 
 
 
 
 
 
 
 
 
 
30 
 
1.10 Rationale (see Figure 1.5) 
1. The ability of RasGrf1 to increase neurite outgrowth has been studied in the 
PC12 cells which express endogenous TrkA (Robinson et al., 2005; Yang and Mattingly, 
2006). Yet the ability of RasGrf1 to induce neurite growth in BDNF-mediated TrkB-
expressing cells, and whether Ras and/or Rac activation is required has not been 
determined. Furthermore, while RasGrf1 is tyrosine phosphorylated in response to 
neurotrophin stimulation in transfected cells in culture, the sites of phosphorylation and 
whether they are essential to RasGrf1 activation has not been determined. 
2. Previous data in our lab suggested that RasGrf1 is tyrosine phosphorylated in 
Human embryonic kidney 293T (HEK293T) and NGF stimulated PC12 cells as well as 
PC12-derived cells over-expressing TrkB. Consequently, the binding sites on both Trk 
and RasGrf1 have been identified, being the HIKE domain located after tyrosine 516 
(amino acids 531-542) on TrkB which binds the N-terminal PH1 domain on RasGrf1 
(Robinson et al., 2005). However, the phosphorylation-dependent interaction of TrkB and 
RasGrf1 has yet to be observed in primary neurons. It was also not determined whether 
TrkB directly interacts with RasGrf1 or if this interaction could be mediated indirectly 
through other scaffolding molecules. Scaffolding proteins are known as crucial regulators 
of many key signaling pathways; they interact or bind to other members of a signaling 
pathway to retain them into their complex. In this regard, post-synaptic density protein 95 
(PSD95) is the intermediate candidate protein. PSD95 is a PDZ (postsynaptic density-95-
discs large-zona occludens-1) domain containing protein that facilitates the 
phosphorylation of NR2B by Src family kinases (Tezuka et al., 1999; Zhang et al., 2008). 
PSD95 co-immunoprecipitates with TrkB and its trafficking to dendrites is facilitated by 
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BDNF (Yoshii and Constantine-Paton, 2007; Ji et al., 2005). Furthermore, RasGrf1 is 
enriched in post-synaptic densities and previously unpublished data in our lab showed 
that PSD95 co-immunoprecipitates with NR2B in response to NMDA treatment. 
3. RasGrf1 has been identified as a novel interactor of both Trk (MacDonald et 
al., 1999), where it facilitates neurite outgrowth in response to low doses of NGF 
stimulation in PC12 cells (Robinson et al., 2005), and the NMDA receptor, where it 
facilitates LTD by activating p38-MAP kinase (Buchsbaum et al., 2002; Li et al., 2006), 
and LTP through Erk-MAP kinase activation (Li et al., 2006). However, the potential of 
RasGrf1, as a downstream signaling molecule, in facilitating a potential cross-talk 
mechanism between the TrkB and NMDA receptors is unknown.  
Thus, the present study has been designed to address the potential of RasGrf1 to 
modulate both TrkB and the NMDA receptors and identify novel cross-talk mechanisms 
by which the biological responses to BDNF are regulated. We have initially determined 
the RasGrf1-induced neurite outgrowth in response to both NGF and BDNF in neuronal-
like cells as an in vitro model for primary neurons. We also examined the domain(s) and 
site(s) of RasGrf1 tyrosine phosphorylation in response to BDNF stimulation in these 
cells. Finally, we determined the interaction between both TrkB and NMDA receptors 
with RasGrf1 in cortical/hippocampal slices, in response to BDNF and NMDA 
stimulation, and provide a potential mechanism of how BDNF activation of TrkB 
facilitates changes in NMDA receptor signaling.   
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Figure 1.5. A schematic diagram to depict the rationales of this study. The question 
marks show signaling molecules or mechanisms involved in the process which remain to 
be investigated in this study. 1) The role of RasGrf1 in neurite outgrowth, the sites of 
tyrosine phosphorylation and its possible downstream Ras and/or Rac-GTPase activation.   
2) Possible interaction of TrkB with RasGrf1. This interaction might be directly or 
indirectly through PSD95. 3) RasGrf1 signaling pathway as a candidate to mediate cross-
talk between TrkB and NMDA receptors during synaptic plasticity, and also RasGrf1-
mediated downstream of Rac/Ras GTPases and p38/Erk MAP kinases activation.  
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1.11 Hypothesis and Objectives 
The general hypothesis of my thesis is that BDNF stimulates the recruitment of 
RasGrf1 to TrkB thereby uncoupling RasGrf1 from the NMDA receptor and decreasing 
the potential of LTD in favour of LTP. Secondly, the ability of RasGrf1 to increase 
BDNF-dependent neuronal/dendritic growth may provide a second mechanism to 
potentiate synaptic connections and facilitate the process of LTP. The specific objectives 
of this project are as follows: 
1. To determine whether the activation of RasGrf1 will increase neurite growth in 
neuronal-like cells in a Ras and/or Rac-dependent manner. 
2. To identify the site(s) of tyrosine phosphorylation on RasGrf1 upon BDNF stimulation.  
3. To determine if BDNF stimulation couples RasGrf1 to TrkB and increases Erk-MAP 
kinase activation. 
4. To determine if BDNF stimulation uncouples RasGrf1 from the NMDA receptor, 
decreases NMDA-induced p38-MAP kinase activation to decrease LTD in favour of 
LTP. 
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Chapter 2 
Ras Guanine nucleotide Releasing Factor 1 (RasGrf1) enhancement of 
Trk Receptor-mediated Neurite Outgrowth requires Activation of both 
H-Ras and Rac 
2.1 Introduction 
The neurotrophin receptor tyrosine kinases, TrkA, B and C, activate diverse signaling 
pathways stimulating distinct cellular responses depending on the cellular context. The 
ligands for the Trk receptors are a family of related proteins termed neurotrophins and 
these include nerve growth factor (NGF) which binds TrkA, brain-derived neurotrophic 
factor (BDNF) which binds TrkB and neurotrophin-3 (NT-3) which binds primarily to 
TrkC (Meakin, 2000; Reichardt, 2006). Upon neurotrophin binding, Trk receptors 
dimerize and undergo a conformational change leading to their activation and subsequent 
trans-phosphorylation on five intracellular tyrosine residues. These sites then recruit 
intracellular signaling molecules essential to signal propagation. Specifically, the 
signaling adaptors Shc and FRS2 competitively bind to Y499 while PLCγ1 binds to Y794 
(Meakin, 2000; Reichardt, 2006; Meakin et al., 1999). In all cases, receptor bound 
molecules become tyrosine phosphorylated which leads to either changes in intrinsic 
enzymatic activity and/or alters the recruitment/activation of subsequent molecules 
(Meakin et al., 1999).  
Recently, we reported the recruitment of the brain-specific Ras-guanine nucleotide 
releasing factor, RasGrf1, to activated TrkA and demonstrated that this process facilitates 
neuronal process formation in PC12 cells (Robinson et al., 2005), a noradrenergic cell 
line derived from a rat pheochromocytoma used extensively to investigate mechanisms of 
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cell survival and differentiation downstream of growth factors and their receptors 
(Greene and Tischler, 1976; Greene, 1978; Vaudry et al., 2002). Herein, we have 
addressed the mechanism regulating the enhanced neurite outgrowth via small GTPases 
of the Ras and Rho-family (Cdc42, Rac and RhoA) (Ridley et al., 1992; Minden et al., 
1995) which are known to serve roles in neuronal growth and differentiation (Nobes and 
Tolkovsky, 1995). TrkA activation of Rac can be stimulated by one of several 
mechanisms including PI3K (Soltoff et al., 1992; Wennstrom et al., 1994; Rodriguez-
Viciana et al., 1997), Ras and/or guanine nucleotide exchange factors. This leads to 
inactivation of RhoA, and the release of stress fiber formation, thereby permitting the re-
organization of actin that is essential to neurite outgrowth (Huang and Reichardt, 2003). 
The specific guanine exchange factors that link NGF stimulated TrkA to Rac activation 
include Kalirin (Chakrabarti et al., 2005) as well as RasGrf1 (Robinson et al., 2005), a 
neuronal protein that is predominantly expressed in the mature brain and is essential to 
learning and memory (Zippel et al., 1997; Giese et al., 2001). RasGrf1 is activated in 
response to both tyrosine phosphorylation from non-receptor tyrosine kinases (Src, 
Ack1), as well as serine/threonine phosphorylation downstream of protein kinase A 
(Farnsworth et al., 1995; Mattingly and Macara, 1996; Kiyono et al., 2000a; Kiyono et 
al., 2000b). Upon activation, RasGrf1 facilitates the exchange of GDP/GTP on Rac 
through its Dbl homology (DH) domain and/or Ras through its C-terminal Cdc25 
domain. Although the sites of Src-dependent tyrosine phosphorylation on RasGrf1 are not 
known, this results in the activation of Rac (Kiyono et al., 2000a). In contrast, Ack-
dependent tyrosine phosphorylation of RasGrf1 stimulates the activation of Ras (Kiyono 
et al., 2000b).  
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In terms of investigating the signaling properties of RasGrf1, previous research has 
shown that its co-expression with H-Ras in PC12 cells promotes constitutive neurite 
outgrowth and cell soma expansion through the activation of both Ras and Rac (Yang and 
Mattingly, 2006). Similarly Baldassa et al., (2007) reported that over-expression of 
RasGrf1 in PC12 cells also stimulated constitutive neurite outgrowth and they suggested 
that this was due to activation of Rac, not Ras, based on transfection studies in HEK cells 
(Baldassa et al., 2007). In both cases, these studies addressed RasGrf1’s effect on 
constitutive neurite outgrowth. In contrast, we have examined mechanisms of RasGrf1-
induced neurite outgrowth in response to both NGF and BDNF. Herein, we demonstrate 
that neurotrophin-dependent neurite outgrowth in PC12 and TrkB-expressing nnr5 cells 
(TrkB-B5) requires activation of both Ras and Rac. Moreover, we demonstrate that co-
expression of RasGrf1 with H-Ras in both PC12 and TrkB-B5 cells, compensate and 
mask the phenotype of function blocking RasGrf1 mutants. Lastly, we demonstrate that 
the co-expression of Trk and RasGrf1 stimulates Rac activation in HEK cells consistent 
with the data of Baldassa et al., (2007). However, comparable studies performed in PC12 
cells reveals NGF-dependent activation of Ras, not Rac. These studies clarify the 
mechanism by which RasGrf1 facilitates neurite outgrowth in response to neurotrophin 
stimulation and demonstrate that RasGrf1 can stimulate different GTPases depending on 
cell type. 
2.2 Materials and Methods 
2.2.1 Reagents. Antibodies to RasGrf1, Cdc42, GST-HRP, Trk (C-14), H-Ras, K-Ras, 
and N-Ras, were from Santa Cruz. Anti-HA was from Roche. H-89 dihydrochloride 
(B1427), and Mouse monoclonal β-actin antibody was from Sigma. Anti-
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phosphotyrosine (p-tyr-100) and anti-Akt (#9272) were from Cell Signaling. Anti-pan 
Ras and anti-Rac1 antibodies were from Transduction Labs. Rabbit antibodies to the 
carboxyl-terminal 14 residues of TrkA (1478) were prepared and affinity purified using 
standard techniques (Robinson, 2008). HRP-coupled goat anti-mouse and goat anti-rabbit 
secondary antibodies were from The Jackson Laboratories. NGF was from Harlan 
Products for Bioscience and human recombinant BDNF was from R&D Systems. The 
DC Protein Assay Kit was from Bio-Rad. 
2.2.2 Plasmids. The following plasmids have been previously described: full-length 
mouse RasGrf1 under control of the human elongation factor 1a promoter (pEFP-
RasGrf1) (Anborgh et al., 1999); pCMX-rat TrkA (wild-type and kinase-dead (KD) 
[K547A]) and rat TrkB (Meakin et al., 1999), TrkA-S10 HIKE domain mutant (Robinson 
et al., 2005). pEGFP was from Clontech. Dominant negative (DN) pcDNA-HA-Rac-N17, 
constitutively active (CA) pcDNA-HA-Rac-G12V, pcDNA-HA-Rac, pEYFP-DN-Ras, 
pEYFP-CA-Ras (G12V) were gifts of S.G. Ferguson (Robarts Research Institute). 
Dominant-negative pcDNA-Cdc42-T17N, CA-Cdc42-Q61L and wild type Cdc42 (in 
pcDNA) were gifts from R. Cerione (Cornell University, Ithaca, NewYork). pcDNA-HA-
H-Ras was the gift from J. Keller (Vanderbilt University Medical Center, Nashville, TN). 
pEFP-RasGrf1-W1056E was from L. Alberghini (University of Milano, Milan, Italy) and 
the RasGrf1 DH minus mutant (pMT3-PH1-IQ-Cat) was from L. Feig (Tufts University 
School of Medicine, Boston, MA). The RasGrf1 S916A mutant was prepared using site-
directed mutagenesis and the mutation verified by DNA sequencing. pGex2T-cRaf-RBD 
was from C. Hermann (Max Planck Institute for Molecular Physiology, Dortmund, 
Germany) and pGex-PAK-CRIB was the gift of G. Pickering (Robarts Research 
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Institute). The si-RNAs against Ras (sense: CCACUAUAGAGGAUUCCUACCGGAA , 
anti-sense: UUCCGGUAGGAAUCCUCUAUAGUGG) and Rac (sense: UUUGACAG 
CACCGAUCUCUUUCGCC , anti-sense: GGCGAAAGAGAUCGGUGCUGUCAAA) 
were from Invitrogen. 
2.2.3 Cell Lines. Human embryonic kidney 293T (HEK 293T) cells were cultured under 
standard conditions in DMEM with 5% supplemented calf serum (SCS) and 5% FBS 
(Hyclone) with 50 µg/ml gentamycin sulfate (Sigma). PC12 rat adrenal 
pheochromocytoma cells were maintained in DMEM with 5% SCS and 5% horse serum 
(Hyclone), while TrkB-B5 (nnR5 cells stably over-expressing HA-tagged TrkB 
receptors) have been described previously (Meakin, 2000; Meakin and MacDonald, 
1998). These were cultured in 5% SCS and 5% horse serum in the presence of 100 µg/ml 
G418 and 50 µg/ml gentamycin sulfate. 
2.2.4 Immunoprecipitations and Western Blots. Transfections were performed 
following standard calcium phosphate (HEK) or Lipofectamine 2000 (PC12 or TrkB-B5 
cells; Invitrogen) techniques using a DNA to Lipofectamine ratio of 1:2. Basically, 1.5 x 
106 cells (100 mm dish) were co-transfected with 0.5-5 µg of each indicated plasmid. 
Lysates were prepared in NP40 lysis buffer (1% Nonidet P-40, 137 mM NaCl, 20 mM 
Tris, 0.5 mM EDTA, pH 8.0) containing 1 mM PMSF, 1 mM sodium orthovanadate 
(NaVO4), 10 µg/ml aprotinin and 10 µg/ml leupeptin and assayed by 
immunoprecipitation. Lysates containing 0.5 to 3.5 mg of protein were 
immunoprecipitated with antibodies (0.5 µg anti-Trk1478, or 1 µg anti-RasGrf1), in 
addition to 5 µl of washed Pansorbin (Calbiochem), at 4 oC overnight. After washing, 
bound proteins were resolved on 6 or 12% SDS-PAGE and transferred to polyvinylidene 
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fluoride (PVDF) membranes. Blocking prior to primary antibody incubation was 
performed for 1 h at room temperature in 10 ml of 10% milk powder and Tris buffered 
saline with tween-20 (TBS-T). Westerns were blotted in primary antibody at 4 oC for 16 
h and then washed for 1 h in TBS-T. Westerns were then blotted in 10 ml 10% milk 
powder and secondary antibody for 1 h at room temperature. Following washes in TBS-T 
for 1 h, westerns were exposed to enhanced chemiluminescence (ECL) reagents and 
developed.  
Primary antibody dilutions are as follows: anti-RasGrf1 1:10,000; anti-Cdc42 
1:2000; anti-GST-HRP 1:2000; anti-Trk (1478) (1:20,000), anti-pTyr100 (1:10,000); 
anti-pan Ras (1:5000); H-Ras (1:5000); K-Ras ( 1:5000); N-Ras (1:5000) and anti-Rac1 
(1:5000), anti-Akt (1:5000), anti-actin (1:20000), and anti-HA (1:5000). HRP-coupled 
secondary antibodies were used at 1:10,000. 
2.2.5 Neurite Response Assay and Analysis of Cell Morphology. Cells were plated 
onto 50 µg/ml poly-D-lysine (Sigma) coated 30 or 100 mm dishes and transfected with 
pEGFP (0.5 µg) plus Empty plasmid (1 µg), pcDNA-HA-Ras (0.5 µg), pEFP-RasGrf1 (1 
µg), pEFP-RasGrf1-S916A (1 µg), pcDNA-RasGrf1-W1056E and/or pMT3-PH1-IQ-Cat (1 
µg) with transfection efficiencies of 70 – 90% (Lipofectamine 2000). Fresh media and 
non-saturating levels of NGF or BDNF (1 ng/ml) were added at 24 h intervals on each of 
4 successive days. Inhibitor H89 (50 µM) was added before stimulation when indicated. 
On each day (from day one at 24 h after transfection to day four), the percentage of EGFP 
transfected cells (> 10 randomly selected fields and at least 200 cells) with neurite length 
greater than 2 cell bodies diameter as well as cells that had a flattened, expanded 
morphology with a width greater than 5 cell body lengths were counted using an inverted 
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fluorescent microscope. Three independent neurite outgrowth experiments (n=3) were 
performed and the percentage of EGFP-transfected cells extending neurites, between 
samples, was statistically analyzed by One way-ANOVA with Post-Tukey test and paired 
student t-test. TrkA and RasGrf1 expression and tyrosine phosphorylation was confirmed 
by immunoprecipitation of 500 µg to 3.5 mg of protein, SDS-PAGE and western blotting 
following the counts performed on day four. The relative densities were then statistically 
analysed by paired student t-test for significant differences between samples (n=3). For 
epifluorescence microscopy, cells were visualized for EGFP on inverted microscopes (1 x 
70 [Olympus]; Diaphot 300 [Nikon]) at a magnification of 200X. 
2.2.6 GTPase binding Assays. pGex2T-PAK-CRIB, pGex2T and GST-Raf1-RBD were 
grown in 50 ml Luria broth (LB) with 50 µg/ml ampicillin for 16 h at 37 °C, added to 500 
ml of LB with 50 µg/ml ampicillin and grown to an OD600 of 0.8 to 1.0. Cultures were 
induced with IPTG (0.2 mg/ml) for 2 h at 37 °C, centrifuged at 5000 rpm for 10 min (4 
°C), re-suspended in 10 ml 1X PBS and frozen at -80 °C. Pellets were re-suspended in 20 
ml of re-suspension buffer (25 mM Tris-Cl pH 7.5, 5 mM EDTA pH 8.0, 150 mM NaCl, 
1 mM PMSF, 1 µg/ml leupeptin) and the bacteria lysed by two passages through a pre-
chilled French press at 20,000 psi. Triton X-100 was added to a final concentration of 1% 
and the sample rotated for 30 min at 4 °C. The sample was then centrifuged at 14,000 
rpm for 10 min at 4 °C. Washed glutathione agarose (500 µl) (Sigma) was added to the 
supernatant and the mixtures incubated for 16 h at 4 °C followed by three washes with 10 
ml 1X PBS and re-suspended in 250 µl interaction buffer (20 mM Hepes, 150 mM NaCl, 
0.05% NP40, 10% glycerol, 1 mM PMSF, 1 µg/ml leupeptin). Laemmli sample buffer 
containing 100 mM DTT was added, samples heated at 65 °C for 10 min and then 
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separated by 12% SDS-PAGE along with known quantities of BSA to estimate the 
amount of GST proteins isolated. HEK cells were transiently transfected with 0.5 - 5 µg 
DNA using the calcium phosphate transfection method and PC12 cells were transfected 
with Lipofectamine 2000. Cells were allowed to express protein for 48 h before 
stimulation with NGF or BDNF (100 ng/ml) for 5 min. A control plate that was serum-
starved was washed 3X with 1X PBS 24 hours before stimulation and serum-free media 
added. Before stimulation, all plates were washed 3X with PBS at 1 h time points before 
stimulation and incubated in serum-free media. Following stimulation, cells were 
incubated for 5 min at 37 °C, followed by a wash with 10 ml PBS. Cells were lysed in 
500 µl interaction buffer for 2 min and lysates centrifuged at 10,000 rpm for 10 min at 4 
°C. Protein concentrations were evaluated with the DC Protein Assay Kit (BioRad). GST, 
GST-PAK-CRIB or GSTRaf1- RBD (approximately 30 µg) was added to 500 µg of each 
lysate and incubated at 4 °C for 16 h. Samples were pelleted at 14,000 rpm and washed 
twice with NP-40 buffer. Laemmli sample buffer with100 mM DTT was added and 
samples heated at 70 °C for 10 min. Proteins were analyzed on 12% SDS-PAGE and 
blotted with anti-GST-HRP (1:5000), anti-Ras (1:2000) or anti-Rac (1:2000). 
2.3 Results 
2.3.1 Trk-dependent RasGrf1 activation facilitates GTP exchange of Rac in HEK 
cells.  
As RasGrf1 is a dual specificity guanine exchange factor for both Ras and Rac, we 
examined which GTPase is preferentially activated downstream of Trk and RasGrf1. In 
particular, RasGrf1 has been shown to activate H-Ras through its Cdc25 domain and 
Rac1 through its DH domain. We initially used HEK 293T cells, co-transfected with 
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TrkA and RasGrf1 and stimulated with NGF, due to their ease of high efficiency 
transfection. GST fused to the CRIB domain of p21-activated kinase (PAK) was used to 
pull activated GTP bound Rac1 from transfected lysates (Baldassa et al., 2007; Small et 
al., 2006) while GST fused to the Ras binding domain (RBD) of Raf1 was used to pull 
activated Ras (Arozarena et al., 2000). As shown in Figure 2.1 (A), CA-Rac1 (lane 3) 
was pulled out by GST PAKCRIB, while a DN-Rac1 (lane 2) showed no binding to GST-
PAK-CRIB. GST alone was used as a control and failed to interact with Rac1 (Figure 
2.1A). An additional control of cells grown under serum-free conditions 24 h before 
stimulation with NGF, showed no basal level of Rac activation (lane 1). While RasGrf1, 
with or without the kinase-dead TrkA, stimulates a basal level of Rac1 activation (lanes 6 
and 7), there is an increase in the activation of Rac1 in the presence of wild type, NGF-
stimulated TrkA (lane 8). The TrkA-HIKE domain mutant (HK) has previously been 
shown to not interact with or phosphorylate RasGrf1 (Robinson et al., 2005) and was 
therefore used to test the specificity of this increase in Rac activation. Accordingly, in the 
presence of this mutant there was a decrease in RasGrf1 activation of Rac1 compared to 
cells expressing wild-type TrkA alone (compare lane 9 to lane 6). These data indicate that 
Rac1 is being activated via TrkA and RasGrf1 in HEK cells. As shown in Figure 2.1B, 
RasGrf1 and TrkA are expressed consistently and RasGrf1 is tyrosine phosphorylated 
upon stimulation with NGF by wild-type TrkA but not the HIKE (HK) domain mutant. 
As RasGrf1 is also a guanine exchange factor for Ras, HEK cells transfected with 
TrkA, RasGrf1 and wild-type, CA or DN-H-Ras were also evaluated for activation of Ras 
through interaction with the Raf1-Ras RBD fused to GST which binds only active, GTP-
bound Ras. As shown in Figure 2.1C, CA-Ras fused to yellow fluorescent protein (YFP-
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RAS-CA) bound to Raf1-RBD-GST as expected (Figure 2.1C, lane 3), while a dominant-
negative construct (YFP-RAS-DN) did not (lane 2). No detectable basal level of Ras 
activation was observed in cells that were serum-starved for 24 h prior to stimulation 
(lane 1) or in cells maintained in serum during this period (lane 4). Unexpectedly under 
these conditions, TrkA alone did not show a detectable level of Ras activation in the 
presence of NGF (lane 5). RasGrf1 did however show a high basal ability to activate Ras 
in the absence of activated TrkA (lane 6) and in the presence of kinase-dead TrkA (lane 
7). However, cells transfected with WT-TrkA and RasGrf1 showed a decrease in active 
GTP-bound Ras (lane 8). To determine whether the loss of interaction between TrkA and 
RasGrf1 would abolish this decrease, cells were transfected with the TrkA-HIKE domain 
mutant instead of wild-type TrkA. These cells showed activation of Ras comparable to 
the TrkA-kinase dead and RasGrf1 transfected cells (lane 9). Thus co-transfection of 
TrkA and RasGrf1 leads to a decrease in Ras activation in HEK cells potentially due to a 
switch in activity toward another GTPase, such as Rac (Figure 2.1A) or due to a re-
localization away from H-Ras upon TrkA binding. Evaluation of RasGrf1 
phosphorylation by TrkA is shown in Figure 2.1D, lane 8, and its lack of phosphorylation 
by kinase-dead TrkA (KD) and the TrkA-HIKE (HK) mutants are shown in lanes 7 and 9, 
respectively. 
While RasGrf1 can be activated downstream of the Rho family GTPase Cdc42, via 
the tyrosine kinase ACK1 (Kiyono et al., 2000b), Cdc42 can in turn be activated by DH 
domain containing guanine exchange factors (Baldassa et al., 2007). For these reasons, 
Trk-activated RasGrf1 was also evaluated for the potential activation of Cdc42. However, 
as shown in Figure 2.1E, we detected no endogenous activated Cdc42, the only GTP-
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bound Cdc42 detected being in cells transfected with CA-Cdc42 (lane 3). There appears 
to be no activation downstream of TrkA or RasGrf1 singly or together (lanes 5, 8). GST 
alone did not interact with Cdc42. Expression and phosphorylation of TrkA and RasGrf1 
in the presence of NGF are shown in Figure 2.1F. 
2.3.2 Analysis of RasGrf1 mutants, and H-Ras, in NGF-induced neurite outgrowth 
in PC12 cells.  
We have previously evaluated the response of PC12 cells to NGF-stimulated TrkA 
and RasGrf1 and have found that these cells have enhanced neurite outgrowth in the 
presence of low doses of neurotrophins (Robinson et al., 2005). The enhanced neurite 
outgrowth is likely mediated through a GTPase such as Ras or Rac1, both of which 
regulate differentiation in PC12 cells. In addition, RasGrf1 over-expression has also been 
reported to constitutively stimulate the flattening and enlargement of the cell soma in 
PC12 cells in the presence of co-transfected H-Ras (Yang and Mattingly, 2006). Yang 
and Mattingly (2006) reported that the expanded cell body required RasGrf1 activation of 
Rac1 and that this was dependent on the co-expression and activation of H-Ras. To 
determine if NGF stimulation potentiated similar changes in the cellular morphology of 
the cell soma, we co-transfected cells with RasGrf1 and H-Ras and evaluated changes in 
both neurite outgrowth and soma size in response to NGF. As shown in Figure 2.2A, we 
similarly observed both phenotypes in cells co-transfected with RasGrf1 and H-Ras. 
Quantification of these phenotypes revealed that cells co-transfected with H-Ras and 
RasGrf1 expressed a higher basal neurite outgrowth (21.6%) response that was 
approximately 3-fold higher than cells expressing H-Ras alone (7%) and that addition of 
NGF stimulated a minor additional increase (27.3%) in neurite outgrowth (Figure 2.2B). 
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Figure 2.2C indicates the levels of Trk and RasGrf1 tyrosine phosphorylation and 
expression. With respect to changes in cell soma size, we observed that co-transfection of 
RasGrf1 and H-Ras also increased the number of cells with increased basal soma size to 
nearly 20% of the total population as compared to control cells transfected with GFP 
alone (4%). However, there was no significant increase in the percentage of cells 
showing an enhanced soma size upon stimulation by NGF in either controls or cells co-
expressing H-Ras and RasGrf1. The levels of Trk and RasGrf1 expression and tyrosine 
phosphorylation are shown in Figure 2.2E.  
To determine whether activation of either Ras, Rac or both facilitate NGF-induced 
neurite outgrowth, PC12 cells were transfected with H-Ras and either wild-type RasGrf1, 
a (W1056E) RasGrf1 mutant which binds GDP-Ras but does not facilitate exchange to 
GTP on Ras (Vanoni et al., 1999), as well as a RasGrf1 (S916A) mutant, the site of protein 
kinase A phosphorylation reported to be required for maximal induction of Ras-
dependent neurite outgrowth in PC12 cells (Yang et al., 2003; Baouz et al., 2001) (Figure 
2.3A). Importantly, the W1056E mutant does not affect the ability of RasGrf1 to activate 
Rac (Vanoni et al., 1999). Cells were stimulated with low levels of NGF (1 ng/ml) for 
four days following transfection and then evaluated for neurites longer than two cell 
bodies in length. As observed in Figure 2.3, RasGrf1 transfected cells showed levels of 
basal neurite outgrowth in the presence of co-transfected H-Ras (23.27% ± 0.37) which is 
only somewhat increased in response to NGF (27.1% ± 0.89) (Figure 2.3B). Interestingly, 
we found that expression of the RasGrf1 (S916A) mutant did not affect either basal levels 
of neurite outgrowth ( 22.93% ± 2.28) or those stimulated by NGF (25.93% ± 3.08 ) 
(Figure 2.3B). Cells transfected with the RasGrf1 (W1056E) mutant exhibited a reduction 
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in neurite outgrowth (17.67% ± 0.65), albeit levels were still higher than cells transfected 
with controls, and we observed a small insignificant increase (20.73% ± 2.3) in neurite 
outgrowth in response to NGF. Analysis of phosphorylation and expression levels 
indicated that wild-type RasGrf1, RasGrf1 (W1056E) and the RasGrf1 (S916A) mutant 
were expressed and phosphorylated at similar levels by NGF-activated TrkA (Figure 
2.3C). 
To further determine whether PKA facilitates RasGrf1-mediated neurite outgrowth in 
response to NGF, via other phosphorylation sites and/or mechanisms, PC12 cells were 
co-transfected with RasGrf1 and H-Ras and then stimulated with NGF in the presence or 
absence of the PKA inhibitor, H89. As shown in Figure 2.3D, we found that application 
of H89 did not lead to a decrease in NGF/RasGrf1-mediated outgrowth suggesting that 
PKA is not important for TrkA-dependent activation of RasGrf1 or enhanced neurite 
outgrowth in PC12 cells under these conditions. Notably, H89 did not affect tyrosine 
phosphorylation levels of either Trk or RasGrf1 stimulated by NGF (Figure 2.3E).  
Since the Ras/Rac activation assays in HEK cells suggested that TrkA activation of 
RasGrf1 resulted in activation of Rac, we next evaluated the potential that RasGrf1 
activation of Rac is involved in mediating NGF-induced neurite outgrowth in PC12 cells. 
Accordingly, cells were co-transfected with H-Ras and either wild-type RasGrf1 or a 
mutant RasGrf1 protein that consists of the PH1 domain, coiled-coil domain and the IQ 
domain fused directly to the Cdc25 domain (PH1-IQ-Cat). This mutant is missing the 
second PH domain and the Dbl homology domain required for binding and facilitating 
GTP exchange of Rac (Buchsbaum et al., 1996). Importantly, this mutant does not affect 
the activation of H-Ras (Yang and Mattingly, 2006). Cells transfected with EGFP showed 
58 
 
very low levels of outgrowth after four days, which was slightly above 5% when 
stimulated with NGF (Figure 2.3F). Cells transfected with the PH1-IQ-Cat RasGrf1 
mutant showed nearly a two-fold increase in the number of cells with neurites in the 
absence of NGF stimulation. Previous studies using the PH1-IQ-Cat mutant revealed that 
it has a slight increase in the basal activity toward Ras, although the reasons for this were 
unclear (Buchsbaum et al., 1996). Interestingly, however, we found that this mutant 
stimulated neurite outgrowth in the presence of NGF and while the levels were decreased 
compared to wild-type RasGrf1, the difference was not statistically different (Figure 
2.3F). The levels of phosphorylation and expression of TrkA, RasGrf1 and PH1-IQ-Cat 
are shown in Figure 2.3G. Taken together, these studies suggest that RasGrf1 mediates 
outgrowth downstream of the Trk receptor through activation of Ras, not Rac1, in 
transfected PC12 cells.  
2.3.3 Trk activation of RasGrf1 facilitates GTP exchange of Ras in PC12 cells.  
The reduction in neurite outgrowth of the RasGrf1 mutant (W1056E) (dominant-
negative for Ras activation) suggested that in PC12 cells, RasGrf1 might be an activator 
of Ras instead of Rac. However, this was in contrast to our observations in HEK cells in 
which we observed an increase in Rac activation but a decrease in the activation of Ras 
downstream of TrkA and RasGrf1 (Figure 2.1). Thus, we performed a GTP binding assay 
on lysates from PC12 cells transfected with wild-type H-Ras and RasGrf1. In these 
studies, RasGrf1 transfected cells showed low levels of basal activation of Ras in the 
absence of stimulation (Figure 2.4A, lane 7). This agrees with our observations of neurite 
outgrowth following co-transfection with H-Ras and RasGrf1 (Figure 2.3). However, 
PC12 cells transfected with RasGrf1 and H-Ras, and stimulated with NGF, showed a 
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considerable enhancement of active GTP-bound Ras (Figure 2.4A, lane 8). This 
activation was comparable to that seen in the positive control lane which expressed CA-
Ras (lane 4). This also agrees with our neurite outgrowth studies in PC12 cells, but 
contrasts with the decreased Ras activation observed in HEK cells suggesting that there 
may be different mechanisms of NGF/TrkA and RasGrf1 signaling occur in the two cell 
types. NGF-dependent Trk and RasGrf1 phosphorylation and expression levels of both 
proteins are shown in Figure 2.4B. 
2.3.4 Trk activation of RasGrf1 does not stimulate increased Rac activation in PC12 
cells.  
Yang and Mattingly (2006) indicated that Ras activation by RasGrf1 promotes 
neurite extension in PC12 cells, but also increases RasGrf1 activity toward Rac. Given 
this data and the Rac activation observed in HEK cells, a GTP binding assay for Rac1 
was also performed in PC12 cells. PC12 cells were co-transfected with RasGrf1 plus WT 
Rac1 as well as CA or DN forms of Rac1 as positive and negative controls. As shown in 
Figure 2.4C, the negative control (DN-Rac1) did not interact with GST-PAK-CRIB (lane 
3) while the CA-Rac1 did (lane 4) relative to GST alone. We observed a small increase in 
Rac activation in NGF stimulated, un-transfected cells (lane 6) and a larger increase in 
un-stimulated cells following transfection with RasGrf1 (lane 7) suggesting that RasGrf1 
over-expression can intrinsically activate Rac. However, we found no discernable 
increase in Rac1 activation in RasGrf1 transfected cells following NGF stimulation above 
the effect of RasGrf1 alone (lane 8). Whole cell lysates were evaluated to verify 
expression of Rac1 as well as to verify expression of RasGrf1 and TrkA and their 
tyrosine phosphorylation status upon NGF-stimulation (Figure 2.4D).  
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2.3.5 PC12 and TrkB-B5 cells express endogenous H-Ras.  
Our initial experiments indicated that RasGrf1 stimulates NGF-induced neurite 
outgrowth in PC12 cells via a Ras, but not Rac-dependent mechanism (Figure 2.3), 
consistent with our subsequent observation that NGF stimulates an increase in RasGrf1-
dependent activation of Ras in PC12 cells (Figure 2.4). However, we were puzzled with 
the observation that the dominant negative RasGrf1 mutant (W1056E) continued to show 
high basal levels of neurite outgrowth in PC12 cells (Figure 2.3) suggesting that either 
another NGF-dependent pathway was also stimulating neurite outgrowth and/or that the 
over-expression of H-Ras was compensating for a loss of function phenotype. The 
original decision to co-transfect RasGrf1 mutants with H-Ras was based on the 
observation by Yang and Mattingly that PC12 cells don’t express endogenous H-Ras 
(Yang and Mattingly, 2006). However, when testing our PC12 and TrkB-B5 cells, we 
found that they do express endogenous H-Ras, but not K-Ras or N-Ras, to levels 
comparable to those observed in brain (Figure 2.5). Thus, to determine whether H-Ras 
over-expression was overcoming the effect of one or more of the RasGrf1 mutants, all 
mutants were re-tested for their ability to support neurotrophin-induced neurite outgrowth 
in the absence of ectopic H-Ras expression. Since RasGrf1 is primarily expressed in the 
brain and is co-expressed predominantly with TrkB, these studies were addressed (as 
described below) in TrkB-B5 cells. We previously generated this cell line from the PC12-
derived cell line, nnR5, that do not express TrkA (Greene and Tischler, 1976), that we 
engineered to stably over-express TrkB (Meakin and MacDonald, 1998).  
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2.3.6 BDNF activation of TrkB also stimulates RasGrf1-dependent enhancement of 
neurite outgrowth via both Ras and Rac.  
Consistent with our observation that RasGrf1 facilitates NGF-dependent neurite 
outgrowth in PC12 cells, we found that BDNF-dependent TrkB activation of neurite 
outgrowth is also significantly enhanced. As shown in Figure 2.6, RasGrf1 expression 
stimulates an enhancement of BDNF-induced neurite outgrowth compared to un-
stimulated cells and un-transfected cells stimulated with BDNF. We then assayed the 
RasGrf1 mutants for changes in BDNF-induced neurite outgrowth, in the absence of H-
Ras co-expression, and as shown in Figure 2.6, both the W1056E and PH-IQ-CAT mutants 
showed a reduction in BDNF-induced neurite outgrowth while the S916A mutant still 
appeared to support significant neurite outgrowth. These observations were next 
quantified in triplicate experiments in the absence and presence of exogenous H-Ras 
expression. As shown in Figure 2.7A, we find that wild type RasGrf1 and the S196A 
mutant show a basal level of neurite outgrowth (11.13% ± 1.87 and 9.86% ± 0.88 
respectively) in the absence of BDNF and a significant increase in the percentage of cells 
showing neurite outgrowth (20.13% ± 2.48 and 16.67% ± 1.68 respectively) in presence 
of BDNF. Wild type RasGrf1 and S916A mutant also showed an approximately 2-fold 
increase in the average neurite length (220 µm and 247 µm) relative to negative control 
of empty plasmid (110 µm) (Figure 2.7B). These results are consistent with our data in 
Figure 2.3 demonstrating that phosphorylation of Ser916 is not essential to neurotrophin-
induced activation of RasGrf1. However, we found that both the W1056E and PH-IQ-CAT 
RasGrf1 mutants significantly reduced BDNF-induced neurite outgrowth to levels 
comparable to negative controls (Figure 2.7A). Interestingly, when cells were co-
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transfected with H-Ras (Figure 2.7D), we found that only the PH-IQ-CAT RasGrf1 
mutant showed a decrease in BDNF-induced neurite outgrowth relative to WT RasGrf1, 
to the levels were still significantly greater than controls. These observations are 
consistent with the results shown above indicating that over-expression of H-Ras masks 
the phenotype of the RasGrf1 mutations. Levels of RasGrf1 and transfected H-Ras 
expression are shown relative to endogenous Akt or actin as loading controls (Figures 
2.7C, E, F). Collectively, these results indicate that RasGrf1 can also act downstream of 
TrkB receptors to enhance BDNF-induced neurite outgrowth.  
2.3.7 Both Ras and Rac si-RNAs block BDNF-induced neurite outgrowth in TrkB 
cells.  
To further determine whether Ras, Rac or both facilitate BDNF-induced neurite 
outgrowth, TrkB-B5 cells were transfected with wild-type RasGrf1 in presence of si-
RNAs against either Ras or Rac1, and the percentage of neurite outgrowth and the 
expression level of Ras/Rac1 were determined. As shown in Figure 2.8A, while wild type 
RasGrf1 significantly (26%) increased neurite outgrowth compared to the negative 
control of empty plasmid (12%), both si-RNAs against Ras and Rac1 decreased neurite 
outgrowth (3.7% and 4.3% respectively) relative to wild type RasGrf1. RasGrf1 co-
transfection with H-Ras also increased neurite outgrowth significantly as expected. 
However, it was included in this experiment as a positive control for si-Ras plasmid. 
These results further support the notion that the activation of both Ras and Rac are 
required for neurotrophin-induced neurite outgrowth. The expression levels of Ras and 
Rac are shown in Figure 2.8B verifying that the level of Ras and Rac expression are 
reduced by the si-RNAs against Ras and Rac. 
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Figure 2.1. Rac/Ras/Cdc42-GTPase pull down assay in transfected HEK cells. Cells 
were transfected with wild type RasGrf1plus CA, DN or WT GTPases as well as kinase 
dead (KD), HIKE domain mutated (HK) or WT TrkA. Forty-eight hours post-
transfection, cells were serum starved for 1 h, stimulated with 100 ng/ml of NGF for 5 
min, lysed and activated GTPases precipitated with indicated GST fusion proteins. 
Samples were immunoprecipitated (IP) and assayed for phosphorylation assessment by 
Western blotting (IB) (Robinson, 2008) (n=3). A) Rac-GTPase activity. Lane 1 represents 
a negative control plate in which cells were starved 24 h. B) Phosphorylation assessment 
of RasGrf1 and Trk during Rac-GTPase activity. C) Ras-GTPase activity. D) 
Phosphorylation assessment of RasGrf1 and Trk. E) Cdc42-GTPase activity. F) 
Phosphorylation assessment of RasGrf1 and Trk. 
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Figure 2.2. Neurite outgrowth assay of wild type RasGrf1 in PC12 cells. PC12 cells 
were transfected with EGFP plus Empty-plasmid or WT-RasGrf1, in presence of H-Ras, 
treated with either NGF (1 ng/ml) for 4 consecutive days or left unstimulated. The 
percentage of cells with neurite length greater than two cell bodies were counted and 
statistically analyzed. Samples were immunoprecipitated (IP), separated by SDS-PAGE, 
and immunoblotted (IB) with indicated antibodies. Three independent neurite outgrowth 
experiments were performomed (n=3). * indicates statistical significance (P-value<0.05) 
of WT-RasGrf1 relative to the Empty plasmid. A) NGF treated PC12 cells co-transfected 
with WT-RasGrf1 and H-Ras. Both neurite extension (A1) and soma expansion (A2) are 
shown. Scale bar is 10µm. B) PC12 cells were co-transfected with WT RasGrf1 and H-
Ras and neurite extension assessed in -/+ NGF stimulation. C) NGF induces tyrosine 
phosphorylation of both Trk and RasGrf1. RasGrf1 band appeared as expected at 
≈140kDa (Robinson, 2008). D) Percentage of PC12 cells co-expressing WT RasGrf1 and 
H-Ras in -/+ NGF stimulation displaying enhanced soma expansion (with expansion > 5-
cell body) (Robinson, 2008). E) Tyrosine phosphorylation assessment for Trk and 
RasGrf1during soma expansion. RasGrf1 band appeared as expected at ≈140kDa 
(Robinson, 2008). 
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Figure 2.3. Neurite outgrowth assay of RasGrf1-mutants in PC12 cells. PC12 cells 
were transfected with EGFP plus either empty-plasmid or WT-RasGrf1 and RasGrf1-
mutants in the presence of H-Ras. Cells were treated with either NGF (1 ng/ml) for 4 
consecutive days or left unstimulated and the percentage of cells with neurite length 
greater than two cell bodies determined. Samples were immunoprecipitated and analyzed 
by SDS-PAGE/Western blot with the indicated antibodies (n=3). * indicates significant 
increase in neurite outgrowth (P-value<0.05) of indicated construct in the presence of 
NGF relative to Empty plasmid. A) Schematic diagram of RasGrf1. RasGrf1 is a multi-
domain protein including PH1(Pleckstrin homology, 50 amino acids), coiled-coil motif 
(CC, 57 amino acids), CaMK binding site (IQ, 88 amino acids), Db1 homology domain 
(DH, 87 amino acids), pleckstrin homology domain-2 (PH2, 66 amino acids), Ras 
exchange motif (REM, 83 amino acids, cyclin destruction box (CDB) and catalytic 
domain (Cdc25, 75 amino acids). In addition, S916A, a PKA phosphorylation site on 
RasGrf1, and the W1056E mutation are indicated. B) Percentage of cells with neurites 
greater than two cell bodies in PC12 cells expressing W1056E and S916A RasGrf1 mutants. 
** indicates significant decrease of W1056E relative to WT-RasGrf1. C) Phosphorylation 
assessment for W1056E and S916A mutants. D) Percentage cells with neurites greater than 
two cell bodies following treatment with H89 (Robinson, 2008). E) Tyrosine 
phosphorylation of RasGrf1 in the presence of H89 (Robinson, 2008). F) PC12 cells were 
co-transfected with the PH1-IQ-CAT RasGrf1 mutant and H-Ras -/+ NGF. Data depicts 
the percentage of cell with neurite length greater than two cell bodies (Robinson, 2008). 
G) Tyrosine phosphorylation of Trk and the PH1-IQ-CAT mutant. The band for this 
mutant appeared as expected under ≈60kDa (Robinson, 2008). 
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Figure 2.4. Ras/Rac-GTPase pull down assay in transfected PC12 cells. Cells were 
transfected with CA, DN, WT Ras or Rac and/or WT-RasGrf1. Forty-eight hours post-
transfection, cells were serum starved for 1 h, stimulated with 100 ng/ml of NGF for 5 
min, lysed and activated GTPases precipitated with the indicated GST fusion proteins. 
Samples were also immunoprecipitated (IP) and western blotted (IB) with the indicated 
antibodies to assess tyrosine phosphorylation (Robinson, 2008) (n=3). A) Ras-GTPase 
activity. The activation of Ras is evident in the presence of RasGrf1 after NGF 
stimulation (lane 8). B) Expression and tyrosine phosphorylation of RasGrf1 and Trk in 
PC12 cells in -/+ NGF stimulation. C) Rac-GTPase activity in transfected PC12 cells. 
The activation of Rac1 is unchanged in the presence of RasGrf1 after NGF stimulation 
(lane 8). D) Expression and tyrosine phosphorylation of RasGrf1 and Trk in transfected 
PC12 cells.  
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Figure 2.5. Evaluation of endogenous Ras expression in PC12 and TrkB-B5 cells. 
Lysates (50 µg) from PC12 and TrkB-B5 cells were immunoblotted (IB) using antibodies 
against H-Ras, N-Ras and K-Ras. Mouse brain tissue lysate was employed as a positive 
control and actin (≈43kDa) served as a loading control (n=3).  
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Figure 2.6. The effect of specific functional mutations on RasGrf1 on neurite 
outgrowth in TrkB expressing PC12-derived cells. TrkB-B5 cells were transfected 
with EGFP and either empty-plasmid, wild type RasGrf1 or the indicated RasGrf1 
mutants, in the absence or presence of co-transfected H-Ras, treated with either BDNF (1 
ng/ml) for 4 days or left un-stimulated (n=3). A) BDNF stimulated TrkB-B5 cells co-
expressing RasGrf1-WT and H-Ras. Scale bar is 10µm. B) The effect of various RasGrf1 
constructs on neurite outgrowth in TrkB-B5 cells in the presence or absence of BDNF 
and without co-expression of H-Ras. Scale bar = 10µm. 
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Figure 2.7. The effect of BDNF on neurite outgrowth in TrkB-B5 cells expressing 
WT and mutant forms of RasGrf1. TrkB-B5 cells were co-transfected with EGFP and 
either empty plasmid, WT-RasGrf1 or the indicated mutants in the absence or presence of 
H-Ras, and -/+ BDNF (1 ng/ml) for 4 consecutive days, and the percentage of cells with 
neurites more than two cell bodies determined. (n=3). * indicates a significant increase in 
neurite outgrowth (P-value<0.05) of indicated construct compared to Empty plasmid. A) 
Expression of WT-RasGrf1 and the S916A mutant resulted in a significant increase in 
neurite outgrowth response. Expression of neither the W1056E, nor the PH1-IQ-CAT 
mutant influenced neurite outgrowth significantly. ** indicates significant decrease of 
PH1-IQ-CAT or W1056E relative to WT-RasGrf1. B) Expression of both RasGrf1 and 
S916A mutant significantly increases the average length of neurites relative to controls. C) 
Expression levels of RasGrf1 constructs in transfected TrkB-B5 cells. Each lane 
represents 50 µg of lysate protein. The PH1-IQ-CAT mutant appeared as expected at 
≈60kDa. The blot was re-probed against Akt (≈55kDa) as a loading control. D) The 
percentage of cells with neurites greater than two cell body lengths in TrkB-B5 cells co-
expressing H-Ras and the indicated RasGrf1 constructs in -/+ BDNF stimulation. Under 
the conditions of H-Ras over-expression the W1056E and PH1-IQ-CAT mutants showed a 
significant increase in neurite outgrowth. E) Expression levels of RasGrf1constructs in 
TrkB-B5 cells co-transfected with H-Ras. F) Expression of endogenous (≈22kDa) and 
co-transfected HA-tagged H-Ras (HA-tagged; ≈24kDa) was determined by SDS-
PAGE/western blot. The blot was first probed with an antibody to H-Ras, stripped and re-
probed with an antibody against HA. The blot was re-probed against β-actin (≈43kDa) as 
a loading control. 
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Figure 2.8. The effect of BDNF-induced neurite outgrowth in TrkB-B5 cells 
expressing si-RNAs against Ras and Rac. TrkB-B5 cells were co-transfected with 
EGFP and either empty plasmid, or WT-RasGrf1 co-expressing with scrambled-RNA or 
si-RNA against Ras or Rac, treated with BDNF (1 ng/ml) for 4 consecutive days, or left 
un-stimulated and the percentage of cells with neurites length greater than two cell bodies 
diameter were determined (n=3). * indicates a significant increase in neurite outgrowth 
(P-value<0.05) of indicated construct in the presence of BDNF compared to Empty 
plasmid, and ** indicates significant decrease of si-Ras/Rac relative to wild type 
RasGrf1. A) Neurite outgrowth assay in TrkB-B5 cells in presence of Ras/Rac si.RNAs 
in -/+ BDNF stimulation. Both si-RNAs against Ras and Rac reduced neurite outgrowth 
significantly in comparing to RasGrf1 wild type. RasGrf1 co-expressing with H-Ras was 
used as a positive control for BDNF-induced neurite outgrowth. B) Expression levels of 
endogenous Ras and Rac in transfected TrkB-B5 cells only in absence of BDNF. Note 
that the expression level of both Ras and Rac was reduced respectively. Expression of 
endogenous (≈22kDa) of H.Ras and Rac as well as co-transfected HA-tagged H-Ras 
(HA-tagged; ≈24kDa, lane 4) as positive control are evident in this blot. The blot was re-
probed against β-actin (≈43kDa) as a loading control. C) A quantification diagram of the 
relative intensity for endogenous Ras (left) and Rac (right) in transfected TrkB-B5 cells 
only in the absence of BDNF (n=3). The blots were normalized to the level of β-actin 
expression.  
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2.4 Discussion 
In this study, we have addressed whether RasGrf1 activates both Ras and Rac in 
response to TrkA and TrkB receptors and whether one or both are essential to NGF and 
BDNF-mediated neurite outgrowth in PC12 and TrkB-B5 cells. We assayed 
Trk/RasGfr1-mediated activation of Ras and Rac in both HEK cells and PC12 cells and 
observed a TrkA-dependent increase in the activation of Rac in HEK cells, while 
activation of Ras in this context was decreased. In contrast, in RasGrf1-transfected PC12 
cells, we observed the opposite response and found that NGF-induced the activation of 
Ras while Rac activity was constitutive and did not appear to change in response to NGF 
stimulation. By comparison, analysis of RasGrf1 potentiation of neurite outgrowth in 
both PC12 and TrkB-B5 cells, and the analysis of site-directed mutants in RasGrf1, 
revealed an essential role for both Ras and Rac in mediating RasGrf1’s enhancement of 
neurotrophin stimulated neurite outgrowth. Our inability to detect NGF stimulation of 
Rac activity in PC12 cells was surprising given that Rac activity is required for neurite 
outgrowth. This may either reflect the fact that RasGrf1 was co-transfected with H-Ras in 
the GTP binding assay or that the kinetics of NGF-induced activation Rac are different 
than Ras and were not detected at the time point used in assay (5 min). We also found 
that the neurotrophin and RasGrf1-dependent enhancement of neurite outgrowth is not 
affected by the site-directed mutant S916A which has been reported as a site of PKA 
phosphorylation and activation of RasGrf1 signaling in PC12 cells (Baouz et al., 2001) as 
well as in neurons of the cerebral cortex (Yang et al., 2003). Moreover, the PKA 
inhibitor, H89, did not affect neurotrophin-induced enhancement of RasGrf1 signaling in 
the neurite outgrowth assays. Altogether, our results show a prominent role for RasGrf1 
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activation of both Ras and Rac downstream of neurotrophin-activated Trk receptors that 
are essential in mediating changes in cellular morphology, specifically, neurite 
outgrowth.   
RasGrf1 has been shown in other studies to be an activator of both Ras and Rac in 
transfected HEK cells. Specifically, in HEK and Cos-7 cells, RasGrf1 activates Ras 
downstream of the non-receptor tyrosine kinase ACK1, cAMP-activated PKA, calcium 
and GPCR activity (Mattingly, 1999; Kiyono et al., 2000b; Yang et al., 2003). 
Conversely, RasGrf1 activates Rac downstream of the non-receptor tyrosine kinase Src 
(Kiyono et al., 2000a). While the specific mechanisms involved in regulating the 
activation of these distinct GTPases in HEK cells have not been determined, it is possible 
that the assembly of scaffolding complexes facilitated by the Trk receptor or its substrates 
may also re-direct the activity of RasGrf1 away from Ras following the initial stimulation 
with NGF. Specifically, RasGrf1 activity toward Rac and p38- MAP kinase, in 
transfected HEK cells, has recently been shown to depend on the assembly of a complex 
involving the scaffolding protein IB2/JIP2 (Buchsbaum et al., 2002). Moreover, RasGrf1 
has also been shown to interact with a microtubule-destabilizing factor SCLIP (SCG10-
like protein) which inhibits its ability to promote Rac activation and neurite outgrowth 
(Baldassa et al., 2007). 
RasGrf1 has also been shown to preferentially activate H-Ras but not N or K-Ras 
(Jones and Jacksonet., 1998). Different Ras subtypes are specific to differentiative or 
proliferative pathways. In particular, H-Ras, but not K-Ras, signaling through the 
Raf/MEK/MAPK pathway requires endocytosis and endocytotic recycling (Porat-Shliom 
et al., 2008). Other Ras types also play specific roles in PC12 differentiation. For 
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example, M-Ras generates sustained activation of Erk and neurite outgrowth in an NGF-
dependent manner (Sun et al., 2006) and RasGrf1 also interacts with M-Ras (Quilliam et 
al., 1999), which is an important protein for the development of dendritic spines in 
primary neuronal cultures (Harvey et al., 2008). RasGrf1 is a neuronal protein and we 
have seen that it alters cellular morphology in response to NGF activated TrkA in PC12 
cells (Zippel et al., 1997; Robinson et al., 2005) as well as BDNF-activated TrkB (this 
study). These studies suggest that within primary neurons, TrkB-activated RasGrf1 will 
serve a role in altering cellular morphology such as branching or dendritic spine density 
through BDNF-dependent activation of RasGrf1 and its subsequent activation of either 
H- or M-Ras.    
The data presented here has noted some important differences in several published 
PC12 studies regarding the importance and expression levels of H-Ras and its effect on 
RasGrf1-mediated differentiation. Yang and Mattingly (2006) did not find detectable 
levels of endogenous H-Ras in their PC12 cell line and did not observe differentiation in 
the absence of over-expression of transfected H-Ras (Baldassa et al., 2007). In contrast, 
in our studies and those by others (Baldassa et al., 2007), we both observed endogenous 
expression of H-Ras and that over-expression of RasGrf1 itself could induce a basal level 
of neurite outgrowth in the absence of NGF. Moreover, we found that co-expression of 
H-Ras with RasGrf1 in PC12 cells stimulated the basal neurite outgrowth response and 
completely eliminated the ability to detect an essential role for Rac in neurotrophin-
induced neurite outgrowth. While Baldassa et al., (2007) observed a specific requirement 
for Rac activation by RasGrf1 in mediating constitutive neurite extension in PC12 cells, 
Yang and Mattingly (2006) observed a requirement for H-Ras co-expression and 
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activation and reported no role for Rac in this process. Instead, they suggested that the 
expansion in soma size in co-transfected cells was dependent on Rac activity (Yang and 
Mattingly, 2006). While we also observed an expansion in soma size in cells co-
transfected with RasGrf1 and H-Ras, this was not observed in either PC12 or TrkB-B5 
cells expressing RasGrf1 alone, in either the absence or presence of neurotrophin 
stimulation. Thus, the expanded 10-fold increase in cell soma size may reflect an artifact 
of H-Ras over-expression. In fact, under conditions of high levels of Ras expression, 
some researchers have reported that Ras is able to directly bind and activate B-Raf and 
small G proteins associated with differentiation (Kao et al., 2001).   
Importantly, our study focused on NGF and BDNF-dependent RasGrf1 enhancement 
of neurite outgrowth. The fact that RasGrf1 specifically alters neuritic growth in response 
to both NGF and BDNF, through the activation of specific Ras family GTPases, suggests 
a potential role for RasGrf1 in mediating Trk-dependent structural changes underlying 
the formation of synapses or dendritic spines in neuronal cells. Such functions would 
further contribute to our understanding of how TrkB and RasGrf1, both essential proteins 
for learning and memory, might be mediating aspects of synaptic plasticity within the 
mature brain. 
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Chapter 3 
A novel site of tyrosine phosphorylation on RasGrf1 guanine nucleotide 
releasing factor 
3.1 Introduction  
Neurotrophins including nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF), neurotrophin 3 (NT3) and neurotrophin 4/5 (NT4/5) initiate their biological 
functions in part by binding to the Trk family of receptor tyrosinse kinases (Meakin, 
2000; Reichardt, 2006).  Upon neurotrophin binding, the two receptor subunits dimerize, 
resulting in tyrosine-autophosphorylation in the intracellular kinase domain. The major 
sites of phosphorylation on rat TrkA include tyrosine 499, 679, 683, 684, and 794. 
Tyrosine residues 679, 683 and 684 form part of the activation loop of the kinase while 
tyrosine 499 and 794 serve as docking sites for intermediate signaling (adaptor) 
molecules (Hanks et al., 1988; Ibanez, 1993; Heldin, 1995; Hubbard, 1997), including 
Collagen homology domain (Shc) family proteins and Fibroblast growth factor Receptor 
Substrate 2 (FRS2) both of which compete to bind Tyr499 and phospholipase Cγ-1 (PLCγ-
1) which binds to Tyr794 (Stephens et al., 1994; Meakin et al., 1999; Minichiello, 2009). 
Through these adaptor molecules, Trk is able to activate three major signaling pathways 
including the Ras-mitogen activated protein kinase (Ras-MAPK) pathway underlying cell 
proliferation and differentiation, the phosphotidylinositol-3 kinase (PI3K)-Akt pathway 
promoting cell survival, and the phospholipase Cγ-1-Ca2+ pathway leading to synaptic 
plasticity (Reichardt, 2006; Minichiello, 2009).  
Although several previous studies suggest that Sos exchange factor couples 
tyrosine kinase signaling pathway to the activation of Ras, and brain-specific guanine 
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nucleotide exchange factor, RasGrf1, couples G-protein signals to the activation of Ras 
(Buday and Downward, 1993; Egan et al., 1993; Shou et al., 1995; Zippel et al., 1996; 
Mattingly and Macara, 1996; Mattingly, 1999), a large body of evidence have indicated 
that Trk can also recruit RasGrf1 to promote neurite outgrowth and differentiation in 
PC12 cells (MacDonald et al., 1999; Ciccarelli et al., 2000; Robinson et al., 2005; Yang 
et al., 2003; Yang and Mattingly, 2006).  
Ras guanine nucleotide exchange factors, namely RasGrfs (Shou et al., 1992), 
previously known as CDC25Mm (Martegani et al., 1992; Wei et al., 1992) belong to a 
family of guanine nucleotide exchange factors (GEFs), and present in two forms of 140 
kDa-RasGrf1 which is highly expressed in the nervous system particularly in the cortex, 
hippocampus and hypothalamus (Zippel et al., 1997; Sturani et al., 1997), and 130 kDa-
RasGrf2 which shows a high sequence homology to RasGrf1 (80%), and is expressed 
ubiquitously, but is also present within mature brain (Fam et al., 1997; Anborgh et al., 
1999).  
Structurally, RasGrf1 is a multi-domain protein (Figure 3.1) including a pleckstrin 
homology (PH) domain in the N-terminus, a coiled coil (CC) and IQ motif, a Db1 
homology domain (DH), a REM motif, a cyclin destruction box (CDB) and a cell 
division cycle 25 (CDC25) domain at the C-terminus. The PH domain is necessary for 
RasGrf1 localization to the plasma membrane (Buchsbaum et al., 1996), and has been 
suggested to bind to phosphoinositides and other types of phospholipids in the membrane 
(Harlan et al., 1994; Lemmon and Ferguson, 2000; Varnai et al., 2002). In addition, the 
PH domain may also serve as a putative phosphotyrosine binding (PTB) domain (Balla, 
2005; Cowburn, 1997), and bind to βγ subunits of G protein-coupled receptors (Touhara 
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et al., 1994; Shou et al., 1995; Mattingly and Macara, 1996; Zippel et al., 1996). This 
domain also interacts with receptor tyrosine kinases through its HIKE motif (Robinson et 
al., 2005). Coiled coil domains play a role in protein-protein interaction in cooperation 
with PH1 and IQ domains. The IQ domain interacts with calmodulin, and in response to 
calcium elevation, RasGrf1 is activated by binding of calcium/calmodulin to the N-
terminal IQ motif (Buchsbaum et al., 1996; Farnsworth et al., 1995). The DH domain 
binds the Rho family of GTPases, in particular Rac1, and promotes guanine nucleotide 
exchange activity toward Rac1 (Freshney et al., 1997; Kiyono et al., 1999; Innocenti et 
al., 1999). The REM motif plays a role in stabilization of the core CDC25 domain, and 
CDB (or PEST) is a region rich in proline, glutamic acid, serine and threonine (PEST) 
amino acids, that constitutes a hypothetical target for proteolysis, an additional 
mechanism to regulate the cellular level of RasGrf1 protein (Rogers et al., 1986; Baouz, 
et al., 1997;; Gnesutta et al., 2001). Lastly, the CDC25 domain facilitates the activation of 
Ras-GTPases (Tian and Feig, 2001; Cen et al., 1993; Wei et al., 1994).  
A role for RasGrf1 is to promote the exchange of GDP for GTP on small GTPases 
such as Ras and Rac, acting as a molecular switch between active GTP-bound and 
inactive GDP-bound states (Tian et al., 2004; Katoh et al., 2000). Small GTPases have a 
crucial role to link external messages from the cell surface to several downstream 
signaling cascades underlying a wide variety of cellular processes including cell cycle 
regulation, cytoskeletal reorganization, neurite outgrowth and differentiation (Crespo and 
Leon, 2000; Malumbres and Pellicer, 1998; Huang and Reichardt, 2003). 
In response to upstream signaling, RasGrf1 not only undergoes serine/threonine 
phosphorylation by protein kinase A (Farnsworth et al., 1995; Schmitt et al., 2005; 
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Mattingly and Macara, 1996), but it has also been documented in several studies that 
RasGrf1 is tyrosine phosphorylated by the non-receptor tyrosine kinase Src, leading to 
the activation of Rac (Kiyono et al., 2000a) and Ack1, resulting in activation of Ras 
(Kiyono et al., 2000b). RasGrf1 has also been shown to be tyrosine phosphorylated by 
the Trk family of receptor tyrosine kinases (Robinson et al., 2005). However, the sites of 
tyrosine phosphorylation, whether they are essential to the enhancement of neurite 
outrgrowth and whether they affect the activation of either Ras or Rac-GTPases have not 
been addressed. 
In this study, we identified novel phosphorylation sites in the CDC25 domain of 
RasGrf1, using site directed mutagenesis, and determined the level of RasGrf1 tyrosine 
phosphorylation by these mutants after either NGF or BDNF stimulation. We also 
examined the ability of these mutants to facilitate NGF-mediated neurite outgrowth in the 
PC12 cell line, a neuronal-like model system widely used to study the mechanisms of cell 
differentiation downstream of TrkA receptor as well as in PC12-derived cells, (namely 
TrkB-B5) over-expressing TrkB receptors.   
3.2 Materials and Methods 
3.2.1 Reagents. Antibodies to RasGrf1(C-20, sc-224), Trk (C-14), anti-H-Ras and anti-
Myc (9E10) were from Santa Cruz. Anti-Rac1 and TrkB antibodies were from BD 
Transduction Laboratories. Mouse monoclonal β-actin antibody was from Sigma. Anti-
phosphotyrosine (p-Tyr-100) was from Cell Signaling. Rabbit antibodies to the carboxyl-
terminal 14 residues of TrkA (1478) were prepared and affinity purified using standard 
techniques (Robinson, 2008). HRP-coupled goat anti-mouse and goat anti-rabbit 
secondary antibodies were from The Jackson Laboratories. NGF was from Harlan 
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Products for Bioscience and human recombinant BDNF was from R&D Systems. The 
DC Protein Assay Kit was from Bio-Rad. 
3.2.2 Plasmids. The following plasmids have been previously described: full-length 
mouse RasGrf1 under control of the human elongation factor 1a promoter (pEFP-
RasGrf1) (Anborgh et al., 1999); pCMX-rat TrkA (wild-type) and rat TrkB (Meakin et 
al., 1999). pEGFP was from Clontech. pcDNA-HA-H-Ras was the gift from J. Keller 
(Vanderbilt University Medical Center, Nashville, TN).  
3.2.3 Cell Lines. HEK 293T cells were cultured under standard conditions in DMEM 
with 5% supplemented calf serum (SCS), 5% FBS (Hyclone), and 50 µg/ml gentamycin 
sulfate (Sigma). PC12 rat adrenal pheochromocytoma cells were maintained in DMEM 
with 5% SCS and 5% horse serum (Hyclone), while TrkB-B5 (nnR5 cells stably over-
expressing HA-tagged TrkB receptors) have been described previously (Meakin, 2000; 
Meakin and MacDonald, 1998). These were cultured in 5% SCS and 5% horse serum in 
the presence of 100 µg/ml G418 and 50 µg/ml gentamycin sulfate. 
3.2.4 Immunoprecipitations and Western Blots. Transfections were performed 
following standard calcium phosphate (HEK) or Lipofectamine 2000 (PC12 or TrkB-B5 
cells; Invitrogen) techniques using a DNA to Lipofectamine ratio of 1:2. Briefly, 1.5 x 
106 cells per 100 mm dish were co-transfected with 0.5-5 µg of each indicated plasmid. 
Lysates were prepared in NP40 lysis buffer (1% Nonidet P-40, 137 mM NaCl, 20 mM 
Tris, 0.5 mM EDTA, pH 8.0) containing 1 mM PMSF, 1 mM sodium orthovanadate 
(NaVO4), 10 µg/ml aprotinin and 10 µg/ml leupeptin and assayed by 
immunoprecipitation. Lysates containing 0.5 to 3.5 mg of protein were 
immunoprecipitated with antibodies (0.5 µg anti-Trk1478, or 1 µg anti-RasGrf1), in 
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addition to 10 µl of washed 50% slurry Pansorbin (Calbiochem), at 4 oC overnight and 
were washed 3 times with fresh NP-40 lysis buffer on the next day. The bound proteins 
from immunoprecipitation or whole cell lysate (WCL) were re-suspended in 25 µl 
Laemmli sample buffer and heated at 65 °C for 10 min. Samples were then resolved on 6-
12% SDS-polyacrylamide gels and transferred (5 volts, 1-2 hours) to polyvinylidene 
flouride membranes (PVDF, Pall Life Sciences). Blocking prior to primary antibody 
incubation was performed for 1 h at room temperature in 10 ml of 10% milk powder and 
Tris buffered saline with tween-20 (TBS-T). Western Blots were incubated with primary 
antibody at 4 oC for 16 h, and then washed for 1 h in TBS-T. Westerns were then blotted 
in 10 ml 10% milk powder and secondary antibody for 1 h at room temperature. 
Following washes in TBS-T for 1 h, westerns were exposed to enhanced 
chemiluminescence (ECL) reagents and developed. Primary antibody dilutions are as 
follows: anti-RasGrf1 1:10,000; anti-Trk (1478) (1:20,000), anti-TrkB (BD Transduction 
Laboratories) (1:2000), anti-Myc (1:2000); anti-pTyr100 (1:10,000); anti-H-Ras 
(1:5000); and anti-Rac1 (1:5000), anti-actin (1:20000). HRP-coupled secondary 
antibodies were used at 1:10,000. 
3.2.5 Neurite Response Assay and Analysis of Cell Morphology. PC12 or TrkB-B5 
Cells were plated onto 50 µg/ml poly-D-lysine (Sigma) coated 30 or 100 mm dishes and 
transfected with pEGFP (0.5 µg) plus Empty plasmid (1 µg), pcDNA-HA-Ras (0.5 µg), 
pEFP-RasGrf1 (1 µg) with transfection efficiencies of 70 – 90% (Lipofectamine 2000). 
Fresh media and non-saturating levels of 1 ng/ml NGF or BDNF (NGF for PC12, BDNF 
for TrkB-B5) were added at 24 h intervals on each of 4 successive days. On each day 
(from day one at 24 h after transfection to day four), the percentage of EGFP-expressing 
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cells in >10 randomly selected fields, at least 200 cells pre field, were scored for neurite 
outgrowth using an inverted fluorescent microscope (1 x 70 [Olympus]; Diaphot 300 
[Nikon]) at a magnification of 200X. The percentages of green cells with a length of 
neurite greater than 2 cell bodies in diameter were calculated. Three independent neurite 
outgrowth experiments (n=3) were performed and the percentage of EGFP-transfected 
cells extending neurites, between samples, was statistically analyzed by One way-
ANOVA with Post-Tukey test and paired student t-test. TrkA and RasGrf1 expression 
and tyrosine phosphorylation was confirmed following the counts performed on day four, 
by immunoprecipitation of 500 µg to 3.5 mg of protein or loading whole cell lysate on 
SDS-PAGE gel and western blotting. The relative densities were then statistically 
analysed by paired student t-test for significant differences between samples (n=3). 
3.3 Results 
New sites of RasGrf1 tyrosine phosphorylation were identified in this study using site 
directed mutagenesis in specific RasGrf1 functional domains followed by analysing their 
effect on neurotrophin-induced neurite outgrowth in PC12 cells or PC12-derived cell 
lines over-expressing TrkB receptor.  
3.3.1 Tyrosine residues Y95 and Y233 in the PH1-IQ domain on RasGrf1 are sites of 
tyrosine phosphorylation.  
Since the PH1 domain of RasGrf1 (Figure 3.1) was determined to interact with 
Trk in vitro (Ciccarelli et al., 2000; Robinson et al., 2005), and the IQ domain is activated 
by calmodulin (Buchsbaum et al., 1996; Farnsworth et al., 1995), the PH1-IQ region of 
RasGrf1 was initially targeted by site directed mutagenesis. Within this region there were 
a total of 7 potential phosphotyrosine acceptor sites (Tyr23, Tyr54, Tyr66, Tyr95, Tyr130, 
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Tyr145, Tyr233) (Figure 3.2A) and while some residues were predicted to be more likely 
sites of phosphorylation, a series of combinatorial mutants were generated (Fig 3-2A). 
Myc-tagged RasGrf1 PH1-IQ domain constructs containing alanine substitution 
mutations at these residues were then co-transfected with TrkA into HEK cells and the 
level of tyrosine phosphorylation determined in response to NGF (Robinson, 2008). As 
shown in Figure 3.2, among the various potential sites of tyrosine phosphorylation on 
PH-IQ, it appeared the NGF stimulation increased the phosphorylation of RasGrf1 wild 
type and PHIQ1, but not PHIQ2 and PHIQ3 (Figure 3.2B). Since the only difference 
between PHIQ2 relative to PHIQ1 is the Y233A on PHIQ2, Y233 is suggested as a major 
site of RasGrf1 tyrosine phosphorylation by NGF-mediated TrkA activation. Moreover, 
these results indicate that residues Y23, Y53 and Y145 are not acceptor sites of tyrosine 
phosphorylation since they were not mutated in the PHIQ2 construct and this construct 
was not phosphorylated. However, residues Y66, 95, 130 could still be sites of additional 
tyrosine phosphorylation as these sites were mutated in both the PHIQ2&3 constructs, 
both of which were not phosphorylated. Thus, to ensure whether the level of decrease in 
phosphorylation in PHIQ2 and PHIQ3 are due to only Y233 or potentially to other sites at 
Y66, Y95 and/or Y130 , two other mutants were generated in the PH1 domain and tested, 
namely, Y95A and Y130A (Figure 3.2A). Interestingly, the results of this experiment 
revealed that the Y95A mutant in the PH1 domain reduced tyrosine phosphorylation levels 
remarkably, suggesting that Y95 is also a target of NGF-dependent phosphorylation of 
RasGrf1 (Figure 3.2C) (Robinson, 2008).  
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3.3.2 Neurite outgrowth is independent of RasGrf1 tyrosine phosphorylation in the 
PH1-IQ domains.  
Given the fact that Y95 and Y233 are the major sites of tyrosine phosphorylation on 
in the PH1-IQ domains in RasGrf1 in HEK cells, changes in NGF-mediated neurite 
outgrowth were next evaluated for the RasGrf1-Y95/233A double mutant (called RasGrf1-
M2) relative to RasGrf1-WT in PC12 cells in the presence of co-transfected H-Ras 
(Robinson, 2008). To ensure that these phosphorylation sites are functionally relevant, 
PC12 cells were transfected with either RasGrf1 wild type or RasGrf1-Y95/233A mutant 
and the percentage of cells with neurite outgrowth was assayed after NGF stimulation. As 
shown in Figure 3.3A, the RasGrf1-Y95/233A mutant increased neurite outgrowth 
significantly (34%) comparable to RasGrf1 wild type (38%) rather than being reduced 
suggesting that Y95/233A sites of tyrosine phosphorylation are not involved in neurite 
outgrowth. The level of RasGrf1 tyrosine phosphorylation of wild type and Y95/233A 
mutant in PC12 cells was shown in Figure 3.3B. The RasGrf1-Y95/233A mutant appears to 
remain phosphorylated in response to NGF in PC12 cells, comparable to RasGrf1 wild 
type (compare lane 6 to lane 4).   
3.3.3 Tyrosine Y1048A and Y1062A in CDC25 domain are involved in RasGrf1 
tyrosine phosphorylation and neurite outgrowth.  
Since it is well documented that RasGrf1 activates Ras by its CDC25 domain, we 
next targeted this region for site-directed mutagenesis. In a study by Vanoni et al., (1999), 
W1056 on RasGrf1 was suggested as a binding site for GDP-Ras-GTPase complex, 
tempting us to consider that tyrosine residues around this area might be involved in 
RasGrf1-mediated neurite outgrowth downstream of Trk. Thus, tyrosine residues Y1048 
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and Y1062 were next targeted by site directed mutagenesis as they were predicted to be 
potential sites of phosphorylation. The prediction has been made based on some criteria 
such as the optimal protein-protein interaction of RasGrf1 and its cognate binding 
proteins, the primary group sequences surrounding these phosphoresidues, and spatial 
configuration for the accessibility of phosphoresidues to be able to predict the location of 
these phosphorylation sites. This new mutant was made from the previous RasGrf1 triple 
mutant (Y95/130/233A) that had been shown to contain major sites of RasGrf1 tyrosine 
phosphorylation in the PH1 and IQ domains (Robinson, 2008). Since RasGrf1 is 
expressed primarily in the brain accordingly with TrkB, neurite outgrowth for RasGrf1-
WT and its mutants were further addressed in TrkB-B5 cells. Thus to ensure that these 
phosphorylation sites, and their effect on neurite outgrowth are functionally relevant, 
TrkB-B5 cells were transfected with RasGrf1-WT and the RasGrf1-M3/M5 mutants in 
the absence of co-transfected H-Ras. As mentioned earlier (Chapter 2), the original idea 
of using H-Ras in PC12 cell study was based on the observation by Yang and Mattingly 
(Yang and Mattingly, 2006) that PC12 cells don’t express sufficient endogenous H-Ras. 
However, at the time of the current experiments, we discovered that both our PC12 and 
TrkB-B5 cells do express endogenous H-Ras. As shown in Figure 3.4B, while RasGrf1-
WT and Y95/130/233A mutant (RasGrf1-M3) demonstrated significant increase (both 
approximately 16%) in neurite outgrowth in comparison to empty plasmid (4%), the level 
of neurite outgrowth was reduced significantly by the RasGrf1-Y95/130/233/1048/1062A mutant 
(RasGrf1-M5) (11%) relative to RasGrf1 wild type, implicating Y1048 and Y1062 are 
primary sites of tyrosine phosphorylation that are important for neurotrophin-mediated 
neurite outgrowth. However, since the RasGrf1-M5 mutant still demonstrated neurite 
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outgrowth that is still significantly increased relative to the negative control (empty 
plasmid), it is possible that there are potentially additional tyrosine phosphorylation sites, 
within the DH domain, that are involved in neurite outgrowth. The level of RasGrf1 
phosphorylation is shown in Figure 3.4C as well as the relative density in right panel. 
While RasGrf1-WT is phosphorylated in response to BDNF, the level of tyrosine 
phosphorylation is significantly (nearly 2-fold) decreased compared to RasGrf1-WT, but 
still detectable, in the RasGrf1-M5 mutant. 
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        1 mqkairlndg hvvtlgllaq kdgtrkgyls krsadnpkwq tkwfallqnl lfyfesdssp 
       61 rpsglylleg sickrapspk rgtsskesge kqqhyftvnf sndsqktlel rtedakdcde 
      121 wvaaiarasy kilateheal mqkylhllqv vetektvakq lrqqledgev eierlktevt 
      181 itnlikdndr iqssnkagsa ddedsdikki kkvqsflrgw lcrrkwknii qdyirsphad 
      241 smrkrnqvvf smleaeaeyv qqlhilvnnf lrplrmaass kkppithddv ssiflnseti 
      301 mflhqifyqg lkarisswpt lvladlfdil lpmlniyqef vrnhqyslqi lahckqnrdf 
      361 dkllkqyeak pdceertlet fltypmfqip ryiltlhell ahtphehver nsldyakskl 
      421 eelsrimhde vsetenirkn laiermiteg ceilldtsqt fvrqgslmqm slsekskssr 
      481 grlgslstkk egerqcflfs khliictrgs ggklhltkng vislidctll depenlddea 
      541 kgagpeiehl efkigvepkd slpftvilva strqekaawt sdiiqcvdni rcnglmmnaf 
      601 eenskvtvpq miksdaslyc ddvdirfskt mnsckvlqir yasverller ltdlrflsid 
      661 flntflhsyr vftnamvvld kliniyrkpm saiparslel lfssshnakl lygdapkspr 
      721 asrkfssppp laigtsspsr rrklslnipi itggkalela slgcssdsya nihspispfg 
      781 kttldtgklc masslpktpe eidvpatipe kpgelsasrk hssdvlkees eddqnhsded 
      841 ntevspvksp ptpksflnrt itefpffnyn ngilmttcrd lvdnnrstls atsafaiata 
      901 ganegpsnke vfrrmslant gfssdqrnid kefvirraat nrvlnvlrhw vtkhtqdfdt 
      961 ddtlkyrvic fleevmhdpd lltqerkaaa niirtltlee tteqhsmlee vilmtegvkt 
     1021 epfenhpale iaeqltlldh lvfksipyee ffgqgwmkae kyertpyimk ttkhfnhvsn 
     1081 fiaseiirne disarasaie kwvavadicr clhnynavle itssinrsai frlkktwlkv 
     1141 skqtkslldk lqklvssdgr fknlreslrn cdppcvpylg myltdlvfie egtpnytedg 
     1201 lvnfskmrmi shiireirqf qqttykidpq pkviqyllde sfmldeesly esslliepkl 
     1261 pt 
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Figure 3.1. A schematic diagrams of RasGrf1 protein. Mouse RasGrf1, a 140kDa 
protein with 1262 amino acids consists of several binding domains including a binding 
domain to interact with TrkB (PH1; pleckstrin domain), and a region that binds with the 
NR2B subunit (amino acids 714-913), coiled-coil motif (CC), ilimaquinone (IQ) domain 
to bind calmodulin, Db1 homology domain (DH) to activate Rac, the second pleckstrin 
domain (PH2), Ras exchange motif (REM), cycline destruction box (CDB), and the 
catalytic domain (CDC25) to activate Ras. S916 is the site for RasGrf1-phosphorylation by 
PKA, the W1056 on RasGrf1 has been suggested as binding site for GDP-Ras, and the 
sequence area encoding amino acids 714-913 have been described as a neural domain 
(ND) which binds the NR2B subunit of NMDA receptor. The lower panel represents an 
amino acids sequence of mouse RasGrf1 with S916 shown in red color. 
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Figure 3.2. Tyrosine phosphorylation analysis of RasGrf1-PHIQ domains mutants 
in HEK cells. Tyrosine phosphorylation levels of RasGrf1 after site directed mutagenesis 
of tyrosine (Y) to alanine (A) in the PH1-IQ domain (Robinson, 2008) (n=3). A) A 
schematic diagram of RasGrf1 presenting the tyrosine mapping in PH1-IQ domains and 
different provided mutants. RasGrf1 contains 7 tyrosine sites in PH1 to IQ domains 
including tyrosine 23, 53, 66, 95, 130, 145, and 233. B) The level of tyrosine 
phosphorylation of RasGrf1 wild type (PHIQ-WT) and its point mutants including 
PHIQ1, PHIQ2, and PHIQ3 in HEK cells in respond to NGF. Note that Y233 involves in 
RasGrf1 tyrosine phosphorylation. C) The level of tyrosine phosphorylation in PH1-Y95A 
and PH1-Y130A point mutants. Note that Y95 appeared to be a site of tyrosine 
phosphorylation. 
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Figure 3.3. Neurite outgrowth assay of RasGrf1 wild type versus Y95/233A mutant 
in PC12 cells. PC12 cells were transfected with EGFP plus Empty-plasmid or RasGrf1-
WT/M2 mutant, in presence of H-Ras, treated with either NGF (1 ng/ml) for 4 
consecutive days or left un-stimulated. The percentage of cells with neurite length greater 
than two cell bodies in diameter were counted and statistically analyzed. Samples were 
immunoprecipitated (IP), separated by SDS-PAGE, and immunoblotted (IB) with 
indicated antibodies (n=3). * indicates statistical significance (P-value<0.05) of RasGrf1-
WT/M2 in presence of NGF relative to the Empty plasmid (Robinson, 2008). A) NGF-
mediated TrkA neurite outgrowth assay of RasGrf1 wild type (RasGrf1.WT) and the 
RasGrf1-Y95/233A mutant in PC12 cells co-transfected with H-Ras. RasGrf1-Y95/233A 
mutant did not reduce neurite outgrowth relative to negative control. B) The level of 
tyrosine phosphorylation of RasGrf1 wild type and Y95/233A mutant in PC12 cells in 
response to NGF. Note that RasGrf1-M2 appeared to be still phosphorylated. 
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Figure 3.4. Neurite outgrowth assay of RasGrf1 wild type versus RasGrf1-CDC25 
domain mutant in TrkB-B5 cells. TrkB-B5 or HEK cells were transfected with EGFP 
plus Empty-plasmid or RasGrf1-WT/M3/M5 mutants (and TrkB construct for HEK cells 
only), treated with either BDNF (1 ng/ml) for 4 consecutive days or left un-stimulated. 
The percentage of cells with neurite length greater than two cell bodies in diameter were 
counted and statistically analyzed. Samples were immunoprecipitated (IP), separated by 
SDS-PAGE, and immunoblotted (IB) with indicated antibodies (n=3). * indicates 
statistical significance (P-value<0.05) of indicated construct in presence of BDNF 
relative to the Empty plasmid, and ** indicates significant decrease of RasGrf1-M5 
relative to wild type RasGrf1. A) A schematic diagram of RasGrf1 presenting the 
tyrosine mapping in CDC25 domain as well as different provided mutants including 
RasGrf1-Y95/130/233A (RasGrf1-M3) mutant in PHIQ domain and RasGrf1-
Y95/130/233/1048/1062A mutant (RasGrf1-M5). RasGrf1 contains 10 tyrosine sites in CDC25 
domain including tyrosine 1048, 1062, 1067, 1115, 1178, 1182, 1196, 1225, 1236, and 
1250. B) Neurite outgrowth assay of RasGrf1 wild type (RasGrf1-WT) and various point 
mutants including triple mutant of RasGrf1-M3 and RasGrf1-M5 mutants in TrkB-B5 
cells in respond to BDNF. RasGrf1-M5 mutant reduced neurite outgrowth significantly 
relative to RasGrf1-WT. C) The level of tyrosine phosphorylation in RasGrf1-WT and its 
M3 and M5 mutants in HEK cells. RasGr1-M5 significantly decreased the level of 
RasGrf1 phosphorylation. A quantification diagram of the relative density for the level of 
tyrosine phosphorylation is shown in right panel (n=3). The blots were normalized to the level of 
RasGrf1 protein expression. 
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3.4 Discussion 
In this study we have addressed novel sites of Trk-induced tyrosine 
phosphorylation in RasGrf1. Although some studies have indicated tyrosine 
phosphorylation of RasGrf1 (Kiyono et al., 2000a&b) downstream of Trk (Robinson et 
al., 2005), the specific site(s) of tyrosine phosphorylation on RasGrf1 have not yet been 
determined. The results here provide evidence about the properties of several tyrosine 
phosphorylation sites in different domains of RasGrf1 including the PH, IQ and CDC25 
domains. These domains have been selected based on a previous study, which 
demonstrated that PH and IQ domains are involved in both the interaction between Trk 
and RasGrf1, and in the level of RasGrf1-tyrosine phosphorylation (Robinson et al., 
2005). Furthermore, Ras activation (compared to Rac1) has been suggested as a 
prominent event for neurotrophin-dependent neurite extension downstream of RasGrf1-
CDC25 domain (Yang and Mattingly, 2006; Chapter 2). 
Firstly, while the PH1 domain of RasGrf1 is the major site of interaction between 
Trk and RasGrf1 (Ciccarelli et al., 2000; Robinson et al., 2005) and we find that it is in 
fact tyrosine phosphorylated in response to Trk activation, these sites of phosphorylation 
are not required during NGF-mediated neurite outgrowth in PC12 cells. The IQ domain 
of RasGrf1 also did not appear to be a site of tyrosine phosphorylation of RasGrf1 during 
NGF-mediated neurite outgrowth, although this domain has been indicated to cooperate 
with the PH domain in the interaction between Trk and RasGrf1 (Robinson et al., 2005). 
This result was expected as the IQ domain was suggested to bind calcium/calmodulin 
kinases in response to calcium (Buchsbaum et al., 1996; Farnsworth et al., 1995), by 
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which RasGrf1 undergoes serine phosphorylation at residue 916 (Farnsworth et al., 1995; 
Schmitt et al., 2005). 
Secondly, we demonstrate that specific tyrosine sites in the CDC25 domain are 
critical for tyrosine phosphorylation of RasGrf1 during neurotrophin-mediated neurite 
outgrowth. Specifically, tyrosine 1048 and/or tyrosine 1062 appear to be crucial for 
neurotrophin-dependent RasGrf1 tyrosine phosphorylation as well as enhanced neurite 
outgrowth. Further study is required to understand whether one or both tyrosine sites are 
necessary for RasGrf1 tyrosine phosphorylation. To answer this question, site directed 
mutagenesis of only Y1048A or Y1062A is recommended for future study. Interestingly, 
both tyrosine sites are located approximately beside Tryptophan 1056 (W1056), a site that 
has been indicated to be crucial for binding of RasGrf1 to Ras-GTPase (Vanoni et al., 
1999). It is possible that these phosphorylation sites cooperate with W1056 to bind and/or 
activate Ras-GTPases.  
Furthermore, in this study, the level of neurite outgrowth in RasGrf1-M5 still 
appeared to be slightly higher (nearly 2-fold) than negative control, and the level of 
reduction in tyrosine phosphorylation of RasGrf1-M5 is not completed, suggesting that 
other tyrosine residues might be involved in RasGrf1 tyrosine phosphorylation to 
maximize neurotrophin-mediated neurite outgrowth. RasGrf1 is also tyrosine 
phosphorylated by Src, which leads to the activation Rac (Kiyono et al., 2000a), 
suggesting that the DH domain of RasGrf1, the domain for Rac activation, might be a site 
of RasGrf1 tyrosine phosphorylation during neurotrophin-mediated neurite outgrowth. 
Since only the PH, IQ and CDC25 domains were investigated in this study, tyrosine 
phosphorylation sites in the DH domain of RasGrf1 remain to be investigated. In this 
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regard, the DH domain has eight tyrosine sites: Y259, Y308, Y337, Y346, Y367, Y384, Y392, 
and Y415, two of which (Y259 and Y415) have been predicted to be sites of tyrosine 
phosphorylation and can be targeted by site directed mutagenesis in future studies. It 
would be also interesting to use this mutant construct to investigate RasGrf1-mediated 
GTPase activity in vitro in PC12 cells and in vivo in primary neuronal cultures to 
understand how tyrosine phosphorylation co-ordinates RasGrf1 toward either Ras or Rac 
activation.  
Collectively, these data suggest a novel site of tyrosine phosphorylation within the 
CDC25 domain of RasGrf1 during neurotrophin-mediated neurite outgrowth, and that 
Y1048 and/or Y1062 are crucial for neurotrophin-mediated neurite outgrowth through 
RasGrf1 downstream of Trk receptors. 
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Chapter 4 
RasGrf1 cross talks between TrkB and NMDA receptors 
4.1 Introduction 
The high affinity tropomyosin-related kinases (Trk), including TrkA, B and C, are 
receptors for a family of closely related growth factors collectively termed the 
neurotrophins. These neurotrophins include nerve growth factor (NGF) which binds 
TrkA, brain-derived neurotrophic factor (BDNF) and neurotrophin 4 (NT4) which bind 
TrkB, and neurotrophin 3 (NT3) which binds TrkC respectively (Meakin, 2000; 
Reichardt, 2006). The Trk receptor tyrosine kinases function primarily in the regulation 
of pathways involved in neuronal differentiation and survival. Of particular relevance to 
my thesis, TrkB regulates synapse development and plasticity in the central nervous 
system in addition to the mechanoreceptive sensory neurons in the peripheral nervous 
system (Reichardt, 2006; Kaplan and Miller, 2000; Huang and Reichardt, 2001).  
The TrkB receptor is expressed widely on both presynaptic and postsynaptic 
membranes of the nerve terminal and dendritic spines inside the brain including the 
cortex and hippocampus. Accordingly, in addition to its well known effects on neuronal 
outgrowth and differentiation, BDNF-mediated TrkB activation is crucial in various 
aspects of synaptic plasticity and modulates dendritic branches and spine formation in the 
entire brain including the cortex, hippocampus, cerebellum and amygdala (Carvalho et 
al., 2008; Lu et al., 2008; Amaral et al., 2007; Minichiello, 2009). 
By indirectly modulating the N-methyl-D-aspartate (NMDA) receptor, BDNF 
contributes in the regulation of the molecular processes of learning and memory namely 
long-term potentiation (LTP) and long-term depression (LTD) (Wu et al., 2004; Xu et al., 
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2006; Kang et al., 1997; Akaneya et al., 1997; Lessmann and Heumann, 1998; Levine 
and Kolb, 2000; Li et al., 1998). The evidence for a role of BDNF-mediated TrkB 
activation of LTP comes from the fact that any deletion in the Bdnf or trkB genes, in vivo 
blocking of BDNF binding to TrkB and/or pre-treating hippocampal slices with TrkB 
antiserum, has been found to either impair or significantly reduce the induction of LTP 
(Reichardt, 2006; Minichiello, 2009). LTP can be observed in the hippocampus, and also 
in other neural structures including the cerebral cortex, cerebellum and amygdala (Bauer 
et al., 2002; Nakazawa et al., 2006; Minichiello, 2009). Furthermore, LTP is dependent or 
independent of the NMDA receptor. However, the NMDA receptor-dependent model of 
LTP has been widely studied in the hippocampal area (Lisman, 2003).  
The NMDA receptor is an ionotropic channel that upon activation by in vivo 
glutamate or in vitro NMDA, allows the intracellular flow of Na+, and to a lesser extent 
Ca2+, as well as extracellular flow of K+. Structurally, it is a heterotetrameric complex 
made up of two obligatory NR1 subunits, and two modulatory NR2 (A-D) subunits which 
control the electrophysiological properties of the NMDA receptor (Kutsuwada et al., 
1992; Monyer et al., 1992; Paoletti, and Neyton, 2007; Kohr, 2006). Although the 
NMDA receptor contributes to both LTP and LTD, several studies suggest that the NR2A 
subunits of the NMDA receptor contribute to LTP whereas the NR2B subunits promote 
LTD (Li et al, 2006; Kollen et al., 2008; Liu et al., 2004; Massey et al., 2004).  
The cell surface localization of the NMDA receptor is regulated by clathrin-
mediated endocytosis in which the 1472YEKL motif on the NR2B subunit serves a critical 
role in this internalization. It has been shown that phosphorylation of tyrosine 1472 
(Tyr1472) in the YEKL motif by Src family kinases uncouples the receptor from clathrin-
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mediated endocytosis and increases the cell surface retention and activity of the NMDA 
receptor (Nakazawa et al., 2001; Prybylowski et al., 2005).  
Although the mechanism by which BDNF regulates NMDA receptor-mediated 
neural plasticity is largely unknown, it appears that BDNF activation of TrkB modulates 
the tyrosine phosphorylation of the NR2B subunit of the NMDA receptors through which 
increases the retention of the receptors on the postsynaptic cell surface (Nakazawa et al., 
2001; Prybylowski et al., 2005). As a result of prolonged surface retention of the NMDA 
receptor, and responding to L-glutamate, the intracellular calcium levels increase in the 
postsynaptic neuron (Minichiello, 2009; Lin et al., 1998; Levine et al., 1998; Levine and 
Kolb, 2000). Increases in the Ca2+ influx in postsynaptic neurons results in the activation 
of a number of signaling molecules including protein kinase C (PKC), protein kinase A 
(PKA) and calcium calmodulin-activated kinases (CaMKII and IV) (Ghosh and 
Greenberg, 1995; West et al., 2001) leading to the initiation of signaling cascades that 
underlie neuronal development and synaptic plasticity (Li et al., 2006; Minichiello, 
2009).  
Among these kinases, PKA and CaMKII have been suggested to activate a Ras 
Guanine nucleotide exchange factor (RasGrf1)-dependent signaling pathway (Farnsworth 
et al., 1995) through phosphorylation of serine 916 (S916) on RasGrf1 (Schmitt et al., 
2005), and tyrosine-phosphorylation, at unknown sites, through non-receptor tyrosine 
kinases such as Src (Kiyono et al., 2000a) or the Cdc42-GTPase-dependent of the kinase 
Ack1 (Kiyono et al., 2000b). 
Ras-Guanine nucleotide Releasing Factors (RasGrfs) consist of two forms: 
RasGrf1 (140 kDa) which is highly expressed in the nervous system (Zippel et al., 1997), 
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and RasGrf2 (130 kDa), which shows a high degree of sequence homology (80%) to 
RasGrf1, and is expressed ubiquitously, but is also present within the mature brain (Fam 
et al., 1997; Anborgh et al., 1999). RasGrfs have been suggested to be a missing link in 
the NMDA receptor regulation of synaptic plasticity. They act as a specific calcium 
sensor to transmit signals from the NMDA receptor to the activation of appropriate 
GTPases and the induction of LTP or LTD (Li et al., 2006).  
It has been suggested that RasGrf1 interacts directly with the NR2B subunit of the 
NMDA receptor (Kraivinsky et al., 2003), through which RasGrf1 stimulates p38/MAP 
kinase activation leading to an increase in LTD. In contrast, RasGrf2 interacts with the 
NR2A subunit of the NMDA receptor and activates Erk/MAP kinase leading to an 
increase in LTP. However, both interactions are observed in a developmental-dependent 
manner, in particular after postnatal day 20 to 25 in the mouse (Li et al., 2006). It has 
been further shown that RasGrf1 promotes p38 activation by Rac in vitro while RasGrf2 
activates Erk-MAP kinase by targeting Ras-GTPases (Buchsbaum et al., 2002; Tian et al., 
2004).  
We have previously identified RasGrf1 as a novel substrate of Trk to facilitate 
neurite outgrowth in response to low doses of NGF stimulation in PC12 cells and BDNF 
stimulation in PC12-derived cells overexpressing TrkB namely TrkB-B5 cells (Robinson 
et al., 2005; Chapter 2). In this study, the potential of RasGrf1 to co-ordinate the 
activation and function of both TrkB and NMDA receptors was addressed using cortical 
and hippocampal slices from postnatal-30 adult mice. Furthermore, the interactions 
between the NR2B subunit and TrkB with RasGrf1 were determined, and the changes in 
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activation of Erk and p38 MAP kinase were characterized in response to BDNF and/or 
NMDA stimulation.  
4.2 Materials and Methods  
4.2.1 Reagents. 
The anti-RasGrf1 (C-20, sc-224), anti-RasGrf2 (sc-7591), anti-Trk (sc-11), anti-NMDA 
NR2B (NMDAε2 sc-1469), anti-NMDA NR2A (NMDAε1 sc-9056), anti-PSD95 (7E3, 
sc-6926), anti-Shc (sc-28883), normal mouse IgG (sc-2343), normal rabbit IgG (sc- 2027 
and normal goat IgG (sc-2028) antibodies were from Santa Cruz. The anti-TrkB mouse 
antibody #1494 was from (BioVision). Mouse anti-TrkB monoclonal antibody (610102), 
anti-ShcC (#610643) and anti-RasGrf2 (#610840) antibodies were from Transduction 
Labs. Rabbit anti-Trk antibodies (Trk1478) to the carboxyl-terminal 14 residues of TrkA 
were prepared and affinity purified using standard techniques (Robinson, 2008). Anti-
phosphotyrosine (p-Tyr-100, #9411S), anti-phospho-p38 MAP Kinase (Thr180/Tyr182, 
#9211S), anti-p38 MAP Kinase (9212), anti-phospho-Erk p44/42 (Thr202/Tyr204, 
#9106S) and anti-Erk p44/42 MAP Kinase (#9102) antibodies were from Cell Signaling. 
HRP-coupled goat anti-mouse, rabbit anti-goat and goat anti-rabbit secondary antibodies 
were from Jackson Laboratories. Human recombinant BDNF was obtained from R & D 
Systems and used at a concentration of 100 ng/ml final. NMDA (M3262) was used at a 
final concentration of 100 µM and was from Sigma. NMDA was used in conjunction 
with 10 mM KCl to promote depolarization.  
4.2.2 Plasmids and Cell Lines. 
The plasmids pEFP-RasGrf1 and pEFP-RasGrf2 (Anborgh et al., 1999), pCMX-rat TrkB 
(wild-type and kinase-dead) have been described previously (Meakin and MacDonald, 
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1998). HEK 293T cells (Graham et al., 1977) were cultured under standard conditions in 
Dulbecco’s modified Eagle media (DMEM) with 5% supplemented calf serum (SCS) and 
5% fetal bovine serum (FBS)(Hyclone) with 50 µg/ml gentamycin sulfate (Sigma). PC12 
rat adrenal pheochromocytoma cells were maintained in DMEM with 5% SCS and 5% 
horse serum (Hyclone). TrkB-B5 [nnR5 cells stably overexpressing HA-tagged TrkB 
receptors (pCMX-HATrkB)] have been described previously (Meakin and MacDonald, 
1998; Meakin, 2000). These cells were cultured in 5% SCS and 5% horse serum in the 
presence of 100 µg/ml G418 and 50 µg/ml gentamycin sulfate. 
4.2.3 Transfections, Immunoprecipitations, Western Blots. 
Transfections were performed following standard calcium phosphate (HEK 293T) or 
lipofectamine 2000 (PC12 cells, Invitrogen) transfection approaches (Jordan et al., 1996). 
Lipofectamine transfection was performed according to manufacturer’s protocol with a 
ratio of DNA to lipofectamine of 1:2. Basically, 1.5 x 106 cells (100 mm dish) were co-
transfected with 0.5-5 µg of each indicated plasmid. Following 48 hrs expression, lysates 
were prepared in NP40 lysis buffer (1% Nonidet P-40, 137 mM NaCl, 20 mM Tris (pH 
8.0), 0.5 mM EDTA) containing 1 mM PMSF, 1 mM sodium orthovanadate (NaVO4), 10 
µg/ml aprotinin and 10 µg/ml leupeptin and assayed by immunoprecipitation. Lysates 
containing 0.5 to 3.5 mg of protein (concentrations determined using the DC Protein 
Assay Kit from Bio-Rad) were immunoprecipitated with 0.5 µg anti-Trk1478, 1 µg 
Trk1494 (BioVision) or 1 µg anti-RasGrf1 as indicated, in addition to 5 µl of washed 
Pansorbin (Calbiochem) or 2 µl γ-bind sepharose (Amersham Pharmacia Biotech) at 4 ºC 
overnight. After washing three times with NP-40 lysis buffer, bound proteins were re-
suspended in 25 µl Laemmli sample buffer and heated at 65 °C for 10 minutes. Samples 
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were then resolved on 6-12% SDS-polyacrylamide gels and transferred (5 volts, 1-2 
hours) to PVDF membranes (Pall Life Sciences). Blocking prior to primary antibody 
incubation was performed for 1 h at room temperature in 10 ml 10% milk powder and 
phosphate buffered saline with tween-20 (TBS-T) or 2% BSA (for phospho-antibodies). 
Westerns were blotted in 10 ml 10% milk powder with primary antibody at 4 ºC for 16 h 
followed by washing in TBS-T for 30 minutes. Westerns were then incubated in 10 ml 
10% milk powder and secondary antibody for 1 h at room temperature. Blots were 
washed for 30 minutes in TBS-T and exposed to enhanced chemiluminescence reagents 
(BioRad) and developed.  
Primary antibody dilutions for western blotting are as follows: anti-RasGrf1 and 
anti-RasGrf2 (Santa Cruz) 1:10,000; anti-RasGrf2 (Transduction Labs) (1:5000), anti- 
Trk(1478) (1:20,000), anti-TrkB 1494 (1:5000), anti-TrkB monoclonal antibody 
(Transduction Labs) (1:2000), anti-NR2B (1:2000), anti-NR2A (1:2000), anti-PSD95 
(1:2000), anti-ShcC (1:2000) and anti-pTyr-100 (1:10,000). anti-phospho-p38 MAP 
Kinase (1:2000), anti-p38 MAP Kinase (1:2000), anti-phospho-Erk p44/42 MAP Kinase 
(1:5000) and anti-Erk p44/42 MAP Kinase (1:5000). HRP coupled goat anti-mouse and 
goat anti-rabbit secondary antibodies were used at 1:10,000 dilution while HRP-coupled 
rabbit anti-goat was used at 1:5000 dilution. 
4.2.4 Neural Slice Analysis. 
Post-natal day 30-35 male CD1 mice were killed with O2/CO2 and their cortices dissected 
into the ice-cold-fresh- 95%O2/5%CO2 saturated Kreb’s Ringer Solution (11.1 mM 
glucose, 1.1 mM MgCl2, 1 mM Na2HPO4, 1.3 mM CaCl2, 25 mM NaHCO3, 120 mM 
NaCl, 4.7 mM KCl). Cortices were then embedded in 2% agarose and 300 µm coronal 
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slices were cut with a vibrotome (frequency 8 Hz, speed 4 Hz). Four slices of cortex (10 
slices of hippocampus) were placed into each well of a 6 well plate and incubated in 2 ml 
Kreb’s Ringer Solution for 1 h at 37° C with 95% O2/5%CO2. Slices were then 
stimulated for 15 minutes at 37 °C with 100 ng/ml BDNF, 100 µM NMDA with 10 mM 
KCl. Slices were removed from Kreb’s Ringer and immediately lysed in lysis buffer A 
(10 mM Tris-HCl pH7.5, 1 mM EDTA, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM 
PMSF, 10 µg/ml aprotinin, 10 µg/ml leupeptin and 1 mM NaVO3). Samples were briefly 
homogenized with a Polytron (2 × 30 second) followed by centrifugation at 1400 rpm for 
10 minutes at 4° C. The supernatant was removed, transferred to microfuge tubes and 
centrifuged again for 20 minutes at 4° C, 14,000 rpm (eppendorf Centrifuge 5417R, 
Hamburg, Germany). A protein assay was performed on each sample using a Bio-Rad Kit 
to determine the protein concentrations in each lysate. For co-immunoprecipitation in 
neural slices, prepared lysates (750 µg to 1.5 mg) were pre-cleared with γ-bind sepharose 
and normal mouse, goat or rabbit IgG (depending on specificity of the primary antibody 
to be used) for one hour. Following centrifugation at 4 °C, 14,000 rpm, supernatants were 
immunoprecipitated with anti- NR2B (1 µg), anti-TrkB (2 µg), anti-NR2A (1 µg) or IgG 
(1 µg) (as a negative control) in LysisA buffer with 2 µl γ- bind sepharose for 16 h at 4 
°C. Immunoprecipitations were washed twice in lysis buffer A, re-suspended in Laemmli 
sample buffer with 100 mM dithiotreitol (DTT) and incubated at 70 °C for 10 minutes. 
Samples were separated by 6% SDS-PAGE and western blotted with indicated 
antibodies. For analysis of phosphorylation of Erk and p38 MAP kinase, Laemmli sample 
buffer with 100 mM DTT was added to whole cell lysates from treated P16 or P30 slices 
and samples incubated at 70 °C for 10 minutes. Samples were separated by 12% SDS-
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PAGE and western blotted as mentioned above. The band intensity was quantified using 
a BioRad imaging system (ChemiDocTM). Relative densities were evaluated compared to 
levels to that in the control lane as indicated in each figure. The means of three separate 
slice preparation were evaluated. Relative densities were then statistically analysed by 
paired student t-test for significant differences between two different stimulation 
conditions. 
4.3 Results 
A coordination of TrkB and NMDA receptors through the downstream signaling 
molecule, RasGrf1, was investigated in this study using post-natal day 30 (P30) acute 
cortical slices after stimulation with either BDNF and/or NMDA. Since several studies 
have suggested that RasGrf1 expression is regulated developmentally in the mouse brain 
(Ferrari et al., 1994; Zippel et al., 1997) with a maximum level being expressed in adult 
mouse cortex (2 months) (Li et al., 2006; Robinson, 2008), this study was performed of 
an age that was optimal for RasGrf1 expression.  
4.3.1 BDNF stimulation disrupts the interaction between NR2B and RasGrf1 in 
neural slices.  
As mentioned earlier, phosphorylation of Tyr1472 on the NR2B subunit of the 
NMDA receptor is necessary to retain the receptors on the cell surface (Nakazawa et al., 
2001; Prybylowski et al., 2005; Wu et al., 2007). Moreover, a direct interaction between 
the NR2B subunit of the NMDA receptor and RasGrf1 has been observed in primary cell 
culture (Krapivinsky et al., 2003). Thus, the phosphorylation status of NR2B and changes 
in RasGrf1 binding to NR2B were determined in adult mouse brain slices after 
stimulation with either BDNF and/or NMDA. As shown in Figure 4.1A, while there is a 
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basal level of Tyr1472 phosphorylation of NR2B under basal conditions (Figure 4.1A, left 
panel, lane 1), this level of phosphorylation is increased more than 2-fold after BDNF 
stimulation (lane 2). In comparison, co-stimulation with NMDA does not stimulate 
Tyr1472 phosphorylation (Figure 4.1A, lane 3) and, in fact, decreases or prevents the 
levels stimulated by BDNF (Figure 4.1A, left panel, lane 4). The expression level of 
NR2B was verified by blotting with the anti-NR2B antibody (Figure 4.1A, lower panel). 
Quantification of the levels of Tyr1472 phosphorylation is shown in the right panel (Figure 
4.1A).  
In addition, a small basal level of interaction between NR2B and RasGrf1 was 
detected in the absence of BDNF/NMDA stimulation (Figure 4.1B, left, lane 1) relative 
to negative control levels obtained with IgG (Figure 4.1B, lane 5), and this interaction 
was significantly increased almost 2-fold in the presence of NMDA (Figure 4.1B, left, lane 
3). However, an interaction between RasGrf1 and NR2B was not observed following 
BDNF stimulation (Figure 4.1B, Lane 2) and the NMDA-induced increase in interaction 
was lost in the presence of BDNF (Figure 4.1B, left, lane 4). This result suggests that 
BDNF-mediated TrkB activation may regulate NMDA receptor signaling by stimulating 
RasGrf1 dissociation from the NR2B subunit. The expression level of NR2B was verified 
using the anti-NR2B antibody (Figure 4.1B, lower panel), and a quantification of the 
levels of NR2B-RasGrf1 interaction, normalized to the level of NR2B, is shown in the 
right panel (Figure 4.1B, right). 
Since NR2A subunit of the NMDA receptor interacts with RasGrf2 (Li et al., 
2006), and the PH domain of RasGrf1 which mediates binding to Trk (Robinson et al., 
2005; Graham et al., 1977) is highly similar to the PH domain of RasGrf2; thus, BDNF-
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dependent changes in the interaction between NR2A and RasGrf2 was also tested. As 
shown in Figure 4.1C, NR2A was co-immunoprecipitated with RasGrf2 in response to 
NMDA (lane 5) stimulation relative to the negative control of IgG alone (Figure 4.1C, 
lanes 1 and 2). However, no loss of NMDA-induced interaction was observed in the 
presence of BDNF (Figure 4.1C, lane 6), which is in contrast to what was observed with 
NR2B and RasGrf1. These data suggest that BDNF stimulation does not change the 
interaction between NR2A and RasGrf2, and that BDNF-TrkB modulation of the NMDA 
receptor is specific to RasGrf1 and NR2B.   
4.3.2 BDNF stimulation increases the association of RasGrf1 towards TrkB.  
A previous study indicated a direct interaction between Trk and RasGrf1 in 
transfected HEK293 cells and consequently, the binding sites on both TrkB and RasGrf1 
have been mapped (Robinson et al., 2005). Thus, the interaction between Trk and 
RasGrf1 was also assessed by co-immunoprecipitation of lysates of P30 cortical slices to 
determine the association of RasGrf1 to TrkB after BDNF stimulation.  
As shown in Figure 4.2A, while there is a basal interaction between RasGrf1 and 
TrkB before stimulation (Figure 4.2A, left, lane 3), relative to negative control of IgG 
(Figure 4.2A, left, lane 7 and 8), this interaction was significantly increased almost 2.5-
fold upon BDNF stimulation (Figure 4.2A, left, lane 4) compared to unstimulated 
condition, indicating that BDNF stimulation increases RasGrf1 association with TrkB. To 
further verify the interaction between TrkB and RasGrf1, an immunoprecipitated sample 
of HEK293 cells, transfected with TrkB and RasGrf1, and stimulated with BDNF was 
also added to this study (Figure 4.2A, left, lane 1 and 2). The level of TrkB expression 
was verified using an antibody against TrkB (Figure 4.2A, left lower panel), and a 
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quantification of the level of interaction is presented in the right panel. Collectively, this 
data as well as the results from the RasGrf1/NR2B dissociation studies suggest that 
BDNF stimulation uncouples RasGrf1 from the NMDA receptor toward the TrkB 
receptor. 
The levels of TrkB and RasGrf1 tyrosine phosphorylation were then analyzed in 
the P30 mouse cortical slices. As shown in Figure 4.2B (left panel), tyrosine 
phosphorylation of TrkB was increased significantly after BDNF stimulation alone (lane 
2), and the site of phosphorylation appeared to be Tyr516 on TrkB (Figure 4.2B, middle 
panel), but not Tyr817 (Figure 4.2B, middle panel). The immunoprecipitation of TrkB was 
verified in all treatment using an anti-TrkB antibody to detect TrkB expression (Figure 
4.2B, lower panels). While TrkB was tyrosine phosphorylated in response to BDNF in 
cortical slices, weak but insignificant levels of RasGrf1 tyrosine phosphorylation were 
detected in both the presence of BDNF alone or in the presence of BDNF and NMDA 
(Figure 4.2C).  
4.3.3 BDNF stimulation modifies the ShcC adapter downstream of TrkB and PSD-
95 downstream of NR2B receptors.   
In addition to a direct interaction between TrkB and RasGrf1 in response to 
BDNF, Shc has also been shown to be tyrosine phosphorylated (Figure 4.3A), and 
interact with Trk (Figure 4.3B), in the presence of BDNF alone and upon stimulation by 
both BDNF and NMDA in P30 cortical slices (Figure 4.3B, lanes 2 and 4), but not in the 
presence of NMDA alone (lane 3) (Robinson, 2008). Furthermore, since RasGrf1 is 
highly expressed at post-synaptic densities (Zippel et al., 1997) and the post-synaptic 
density protein 95 (PSD-95) is a major regulator of NMDA receptor signalling, that 
123 
 
facilitates the phosphorylation of NR2B by Src family kinases (van Zundert et al., 2004). 
Thus, it is likely that NMDA would facilitate an interaction between NR2B and PSD-95. 
As shown in Figure 4.3C (Robinson, 2008), a basal level of interaction was observed 
between NR2B and PSD-95 in absence of any treatment (lane 1), but this interaction was 
remarkably increased in treatment by NMDA alone (lane 3) similar to what observed 
between RasGrf1 and NR2B (Figure 4.1B, lane 3).  
Since we found that the site of BDNF-induced tyrosine phosphorylation on TrkB 
was tyrosine516 (Figure 4.2B), the docking site for ShcC (Minichiello, 2009), I addressed 
whether ShcC might also form a complex with RasGrf1 which binds the adjacent HIKE 
domain (His531 to Glu542) on TrkB and whether RasGrf1 might form part of a signalling 
complex downstream of the NMDA receptors. Thus, I tested for direct interactions 
between RasGrf1 and both PSD-95 and ShcC under basal or stimulated conditions. 
However, no interaction was observed between RasGrf1 and either ShcC or PSD-95 in 
response to either BDNF or NMDA stimulation in this study (Figures 4.3D and 4.3E).  
4.3.4 BDNF stimulation alters NMDA-mediated Erk and p38-Map Kinase 
phosphorylation in an age specific manner. 
A study by Li et al (2006) suggests that NR2B/RasGrf1 interaction increases the 
activation of p38, while NR2A/RasGrf2 interaction enhances the activation of Erk 1 and 
2 (Li et al., 2006). Thus, the phosphorylation levels of the p38 and Erk MAP-kinases 
were evaluated in this study, in response to BDNF and/or NMDA.  
As shown in Figure 4.4A, a basal level of Erk1/2 was observed under basal 
conditions (Figure 4.4A, lane 1). Subsequently, a small but significantly higher level of 
Erk phosphorylation was observed in response to 15 minutes of BDNF stimulation 
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relative to the unstimulated condition (lane 2). While NMDA treatment did not stimulate 
a change in levels of Erk phosphorylation relative to controls, a significant decrease in 
Erk1/2 phosphorylation was observed after treatment with both BDNF/NMDA (Figure 
4.4A, lane 4) relative to that observed with BDNF treatment alone. The levels of Erk 
expression are shown in the lower panel of Figure 4.4A and a quantification of the levels 
of Erk phosphorylation is shown in the right panel. 
With respect to p38, I found basal levels of p38-MAP kinase phosphorylation 
under both basal conditions and following BDNF stimulation (Figure 4.4B, lane 2). In 
contrast, I observed a substantial increase (almost 2-fold) in the levels of p38 
phosphorylation upon NMDA treatment (lane 3). When slices were co-stimulated with 
both BDNF/NMDA, there was a slight decrease, that was not statistically significant, in 
the level of p38-MAP kinase phosphorylation and the levels of phosphorylation were still 
significantly higher than unstimulated controls (lane 4). Quantification of the levels of 
p38 phosphorylation, are shown in the right panel. Collectively, these observations 
suggest that BDNF stimulation modulates the activity of Erk and p38-MAP kinase 
downstream of NMDA receptor. 
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Figure 4.1. The phosphorylation of NR2B and its interaction with RasGrf1 in P30 
brain slices. Cortical slices were lysed after BDNF and/or NMDA stimulation, and 3 mg 
lysates were immunoprecipitated (IP) with the NR2B or NR2A antibodies. Ips or a whole 
cell lysate (WCL; 100 µg) were analyzed by SDS-PAGE, and blotted (IB) with the 
indicated antibodies (n=3). * indicates statistical significance (P-value<0.05) of indicated 
condition relative to unstimulated condition. A) Tyrosine1472 phosphorylation assessment 
of NR2B subunit in WCL in response to BDNF and/or NMDA (n=3). The level of 
Tyr1472 phosphorylation was increased more than 2-fold in the presence of BDNF relative 
to the unstimulated lane. Relative density of this phosphorylation levels are shown in the 
right panel. The blots were normalized to the level of NR2B expression. B) Interaction 
between NR2B and RasGrf1 upon BDNF and/or NMDA stimulation in P30 slices. NR2B 
interaction with Ras-Grf1 was increased almost 2-fold in response to NMDA relative to 
the unstimulated lane, and BDNF prevents this interaction. Goat immunoglobulin (IgG) 
was used as a negative control. A quantification of the interaction levels are shown in the 
right panel. Blots were normalized to the levels of NR2B expression.  C) The interaction 
between NR2A and RasGrf2. BDNF stimulation does not change the interaction between 
RasGrf2 and NR2A (Robinson, 2008).  
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Figure 4.2. The interaction between Trk and RasGrf1 and the level of Trk/RasGrf1 
phosphorylation in P30 brain slices. Cortical slices were lysed after BDNF and/or 
NMDA stimulation, and 2 mg of lysates immunoprecipitated (IP) with Trk (C-14) or 
RasGrf1 (C-20) antibodies. Ips or a whole cell lysates (WCL; 100 µg) were analyzed by 
SDS-PAGE, and blotted (IB) with the indicated antibodies (n=3). * indicates statistical 
significance (P-value<0.05) of indicated condition relative to unstimulated condition. A) 
Interaction between Trk and RasGrf1 (n=3). An enhanced interaction (almost 3-fold) 
between TrkB and Ras-Grf1 is evident in response to BDNF relative to the unstimulated 
lane,.Co-stimulation with NMDA decreases this interaction. Rabbit immunoglobulin 
(IgG) was used as a negative control for immunoprecipitation. A quantification diagram 
of the interaction between Trk and RasGrf1, normalized to the level of Trk in each lane, 
is shown in the right panel. B) Tyrosine phosphorylation of TrkB. BDNF stimulation 
increases the tyrosine phosphorylation of tyrosine516, not tyrosine817, on TrkB. C) 
Tyrosine phosphorylation of RasGrf1. A weak-insignificant level of tyrosine 
phosphorylation is detectable in the presence of BDNF and both BDNF/NMDA 
treatment. 
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Figure 4.3. Western blot analysis of complex signaling molecules downstream of 
TrkB and NR2B in P30 mouse brain slices. Cortical slices were lysed after BDNF 
and/or NMDA stimulation, and immunoprecipitated (IP) with the indicated antibodies. 
Ips or whole cell lysates (WCL) were analyzed by SDS-PAGE and blotted (IB) with the 
indicated antibodies (n=3). A) The level of ShcC phosphorylation upon BDNF 
stimulation. ShcC tyrosine phosphorylation is increased in the presence of BDNF 
(Robinson, 2008). B) The interaction between ShcC and TrkB after BDNF and/or NMDA 
stimulation. BDNF stimulation increases Trk-ShcC interaction (Robinson, 2008). C) The 
interaction between PSD-95 and NR2B after BDNF and/or NMDA stimulation. NMDA 
stimulation increases the NR2B-PSD-95 association (Robinson, 2008). D) The 
interaction between ShcC and RasGrf1, as being part of a complex, after BDNF and/or 
NMDA stimulation. No interaction was observed between RasGrf1 and ShcC in any 
condition. E) The interaction between PSD-95 and RasGrf1, as being part of a complex, 
after BDNF and/or NMDA stimulation. No interaction was observed between RasGrf1 
and PSD-95 in any condition. 
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Figure 4.4. The activation of Erk/p38 MAP-kinase activation upon BDNF and/or 
NMDA stimulation. Cortical slices were lysed after BDNF and/or NMDA stimulation, 
and a whole cell lysates (WCL; 100 µg) were analyzed by SDS-PAGE, and blotted (IB) 
with indicated antibodies (n=3). * indicates statistical significance (P-value<0.05) of 
indicated condition relative to unstimulated. A) The phosphorylation of Erk in P30 slices 
after BDNF and/or NMDA stimulation. The level of Erk phosphorylation is increased 
significantly after BDNF stimulation alone relative to the unstimulated lane, and was 
decreased in combination treatment relative to BDNF alone. Quantification of Erk 
phosphorylation, normalized to levels of Erk expression, is shown in the right panel. ** 
indicates significant decrease of combination treatment relative to BDNF alone. B) The 
phosphorylation of p38 in P30 slices after BDNF and/or NMDA stimulation. NMDA 
stimulation alone increased significantly (almost 2-fold) the level of p38 phosphorylation, 
relative to unstimulated cells, and the level of phosphorylation was decreased in 
combination treatment. Quantification of p38 phosphorylation, relative to levels of p38 
expression, is shown in the right panel. 
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Figure 4.5. A schematic diagram depicting the proposed model of RasGrf1-mediated 
cross-talk between TrkB and NMDA receptors. Note that intracellular Ca2+ is a key 
determinant in generating LTD or LTP. In the absence of BDNF (A), RasGrf1 binds to 
the NR2B subunit of the NMDA receptor. Subsequently, p38-MAP kinase is activated 
predominantly through Rac-GTPases. This activation leads to NMDA receptor 
internalization, low Ca2+ influx and LTD. In the presence of BDNF (B), TrkB is 
activated, leading to Src-mediated phosphorylation of NMDA receptor on Tyr1472. NR2B 
is stabilized on cell surface which blocks LTD, consequently intracellular Ca2+ levels are 
increased, result in activation of PKA, and phosphorylation of RasGrf1 at Ser916 with 
the resultant dissociation of RasGrf1 from the NR2B. This dissociation allows for the 
RasGrf1 to directly interact with TrkB and mediate the activation of signaling pathways 
leading to neuritogenesis. Increase in the level of intracellular Ca2+ also associate NMDA 
receptor to LTP on receptor level. 
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4.4 Discussion 
LTP and LTD, two molecular processes contributing in learning and memory 
formation, are regulated in part by the NMDA receptor in the hippocampus area of the 
brain, and it has been suggested that BDNF increases both hippocampal presynaptic and 
postsynaptic transmission by regulating the activity of the NMDA-NR2B receptor 
(Levine and Kolb, 2000). Through postsynaptic TrkB receptor activation, BDNF 
increases the NMDAR single-channel-open probability associated with both LTP and/or 
LTD. In fact, it has been shown that blocking the NR2B subunit of the NMDAR inhibits 
LTD with no effect on LTP, while NR2A inhibition prevent LTP induction but not LTD 
(Lu et al., 2008; Liu et al., 2004). In this regard, synaptic plasticity is associated with an 
increase in MAP kinase family members activated downstream of both NMDA receptors 
(Levine and Kolb, 2000), and BDNF-mediated TrkB receptors. While several documents 
have addressed the nature of the cross talk between NMDAR and TrkB, the signalling 
pathways downstream of these receptors are not fully understood. 
Previous results from the Meakin Lab (Robinson, 2008) indicate that RasGrf1 is 
expressed at very low levels in the neonate, and levels rise developmentally with the 
maximum expression predominantly in the mature brain (>P30) which was consistent 
with a previous study (Zippel et al., 1997). Thus, all analyses in this study have been 
addressed in P30 CD1 mice. Moreover, acute cortical slices including cortex and 
hippocampus were used in this study as these areas have been suggested to express 
BDNF and TrkB associated with plasticity, LTP and LTD (Li et al., 2006). Consequently, 
BDNF stimulation appeared to sustain Tyr1472 phosphorylation of the NR2B subunit of 
the NMDA receptor similar to what has been observed in other studies (Lin et al., 1998; 
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Levine et al., 1998; Levine and Kolb 2000). As mentioned earlier, the phosphorylation of 
NR2B-Tyr1472 is crucial to retain NMDA receptor on cell membrane (Nakazawa et al., 
2001; Prybylowski et al., 2005).  
Moreover, there was a direct interaction between the NR2B subunit of the NMDA 
receptor and RasGrf1 in the presence of NMDA in P30 cortical slices which is in 
agreement with previous studies (Kraivinsky et al., 2003; Li et al., 2006), and the level of 
interaction was reduced remarkably by the addition of BDNF. In vitro studies in TrkB-B5 
cells further verified that NMDA treatment increases the association of NR2B with 
RasGrf1 similar to that observed using brain slices (Robinson, 2008).  
A relevant interaction was also observed between TrkB and RasGrf1 in P30 
cortical slices in response to BDNF stimulation, which is consistent with previous 
observations in HEK293 cells (Robinson et al., 2005). BDNF stimulation increased 
tyrosine phosphorylation of the TrkB receptor at Tyr516, equivalent to Tyr499 on TrkA, 
which is the docking site for the ShcC adaptor protein (Minichiello, 2009). Since this site 
is close to the HIKE domain (His507-Glu518) on TrkA, the binding site of RasGrf1, the 
question arose as to whether ShcC might be interacting with RasGrf1. While a direct 
interaction between TrkB and ShcC was observed after BDNF stimulation, no direct 
interaction between ShcC and RasGrf1 was observed. 
Furthermore, an increase in interaction between NR2B and PSD-95 was also 
observed upon NMDA treatment (Robinson, 2008), and a loss of this interaction occurred 
following the addition of BDNF similar to what was observed between NR2B and 
RasGrf1, suggesting that RasGrf1 might be part of a complex with the PSD-95 
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intermediate signalling molecule. However, when interactions between PSD-95 with 
RasGrf1 were examined, no interactions were observed. 
While both NGF and BDNF have been shown to stimulate tyrosine 
phosphorylation of RasGrf1 in transfected cells in culture (Robinson et al., 2005; Chapter 
2), I was unable to detect sufficient levels of RasGrf1 tyrosine phosphorylation in this 
study, even by using 20 mg of lysates (data not shown). This data suggests that RasGrf1 
either is not phosphorylated in vivo, opposite to what we have observed in vitro, or that 
the levels of phosphorylation are stoichiometrically low and can only be detected in other 
conditions such as using higher levels of lysate, specifically examining post synaptic 
density fractions or using a more specific antibody in future studies. 
In this study, the phosphorylation of the Erk/MAP kinase after BDNF treatment 
alone was increased significantly compared to that observed in untreated conditions while 
the level of p38 phosphorylation was increased significantly after NMDA stimulation . In 
fact, this data suggests that interaction between RasGrf1 and TrkB has been associated 
with an increase in Erk-MAP kinase phosphorylation while interaction between RasGrf1 
and NR2B has been associated with an increase in p38-MAP kinase phosphorylation. 
This data is not in agreement to what observed in the study by Krapivinsky et al., (2003) 
in which an interaction between RasGrf1 and NR2B has been associated with increased 
in Erk phosphoryation. In contrast, the results presented here agree with the study by Li 
et al (2006) in which the interaction between RasGrf1 and NR2B specifically activated 
p38 MAP Kinase but not Erk associated with increases in long-term depression, while the 
association of RasGrf2 with NR2A facilitates Erk activation with the result of promoting 
LTP (Li et al., 2006).  
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Furthermore, in terms of regulating the balance between Erk and p38-MAP kinase 
phosphorylation by either BDNF or NMDA, it appears that the NMDA- mediated NR2B 
activation shows a stronger influence than the BDNF-mediated TrkB activation as the 
combination treatments in Erk-MAP kinase phosphorylation, adding NMDA to BDNF 
significantly blocked Erk phosphorylation while in p38-MAP kinase phosphorylation 
assessment, adding BDNF to NMDA only slightly decreased p38 phosphorylation. These 
observations suggest that RasGrf1 might initiate part of a signalling pathway upstream of 
Erk and that some other signalling molecules with distinct consequences rather than 
RasGrf1-mediated neuronal growth might be also involved in Erk phosphorylation. Since 
RasGrf2 associates with NR2A to facilitate the activation of Erk (Li et al., 2006) and 
since the interaction between NR2A and RasGrf2 was unaffected by BDNF, I expected to 
observe a slight increase in the level of Erk activation. While this additive effect was not 
observed under the conditions used, it is possible that it is transitory or may be revealed 
in another time point or by performing more careful analyses of the kinetics of Erk 
activation in slice cultures. Moreover, the distinct role(s) of RasGrf1 and RasGrf2 in 
mediating Erk activation need to be further investigated, and future studies using slices 
from RasGrf1 and RasGrf2 knockout mice could verify distinct roles of each in 
regulating in Erk activation. 
This study presents important data demonstrating that signalling cross-talk occurs 
in response to BDNF and NMDA stimulation within cortical and hippocampal slices of 
the brain (see proposed model in Figure 4.5). While BDNF recruits and couples both 
ShcC and RasGrf1 to the TrkB receptor, the later of which is uncoupled from the NR2B 
subunit of the NMDA receptor, co-stimulation with NMDA uncouples RasGrf1 from 
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TrkB but does not affect TrkB binding to ShcC. Conversely, while NMDA stimulates 
NR2B binding to PSD-95, co-stimulation with BDNF uncouples this interaction. The 
evaluation of co-ordination between TrkB, NR2B and RasGrf1 in specific regions, such 
as postsynaptic density, may further clarify the nature of this signalling pattern.  
Since RasGrf1 increases neurite outgrowth in PC12 cells upon NGF and BDNF 
stimulation, and given the fact that TrkB regulates dendritic spine density and synapse 
formation, the evaluation of hippocampal neurons from RasGrf1 knockout mice in the 
presence of BDNF may identify a potential role of RasGrf1 and TrkB in neurons to 
modulate potential synaptic morphology. It would be interesting to investigate if BDNF 
and/or NMDA stimulation affects dendritic spine density in wild-type versus RasGrf1 
knockout hippocampal cultures to address whether NR2B activation of p38-MAP kinase 
and LTD are associated with a loss of dendritic spines. Furthermore, RasGrf1-siRNA 
could be used to knock down RasGrf1 expression in hippocampal cell cultures in the 
absence and presence of BDNF and evaluate dendritic spine density.  
Collectively, a novel signalling pathway was identified in this study within the 
mature brain where BDNF-mediated TrkB activation modifies NMDA receptor 
signalling pathway through RasGrf1 to link synaptic plasticity to neuronal differentiation.  
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Chapter 5 
General Discussion and Conclusions  
The mechanism of coordination between TrkB and NMDA receptor through RasGrf1 
has been addressed in this study and the possible signaling molecules downstream of 
RasGrf1 were investigated.  
Initially to understand a role for RasGrf1 in cell differentiation, RasGrf1-mediated 
neurite outgrowth was determined in an in vitro neuronal-like model, PC12 cells and 
TrkB receptor over-expressing cells. It appeared that RasGrf1 activates both Ras and Rac 
during neurotrophin-mediated neurite outgrowth (Chapter 2). By using several 
domain/site- directed mutants of RasGrf1 in a comparison study including NGF-mediated 
neurite outgrowth in PC12 cells versus BDNF-mediated in TrkB-B5 cells, it has been 
revealed that both Ras and Rac-GTPases are essential in neurotrophin-mediated 
enhancement of neurite outgrowth through RasGrf1. This notion is consistent with other 
studies in which RasGrf1 activates Ras in HEK cells downstream of the non-receptor 
tyrosine kinase ACK1, cAMP-activated PKA, calcium and GPCR activity (Mattingly, 
1999; Kiyono et al., 2000b; Yang et al., 2003). Conversely, RasGrf1 activates Rac 
downstream of the non-receptor tyrosine kinase Src (Kiyono et al., 2000a). Furthermore, 
Baldassa et al., (2007) have shown that RasGrf1 interacts with a microtubule-
destabilizing factor SCLIP (SCG10-like protein) which inhibits its ability to promote Rac 
activation and neurite outgrowth (Baldassa et al., 2007). 
It has been denoted in this study to take extreme precaution regarding the expression 
of endogenous H-Ras while using the PC12 cell line, as the level of endogenous H-Ras 
could explain some differences in the results of various studies performed in PC12 cells. 
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For instance, Yang and Mattingly (2006) reported no detectable levels of endogenous H-
Ras expression in their PC12 cell line and they found a requirement for H-Ras co-
expression in order to stimulate neurite extension. Moreover, they reported no role for 
Rac in this process; rather, they have suggested that the expansion in soma size in co-
transfected cells was dependent on Rac activity (Yang and Mattingly, 2006). In contrast, 
in this study and others (Baldassa et al., 2007), the level of endogenous H-Ras was 
detectable and it was sufficient to induce neurite outgrowth in presence of RasGrf1 
expression. Consistently, Baldassa et al., (2007) observed a specific requirement for Rac 
activation by RasGrf1 in mediating constitutive neurite extension in PC12 cells. In 
addition, in this study, I found that the co-expression of H-Ras with RasGrf1 in PC12 
cells highly induced neurite outgrowth, and could completely eliminate the ability to 
detect Rac activity in neurotrophin-induced neurite outgrowth. In fact, some researchers 
have also reported that Ras is able to bind and activate b-Raf and small G proteins 
associated with differentiation under conditions of high levels of Ras expression (Kao et 
al., 2001).   
In addition to the evidence provided here to indicate RasGrf1 regulation of Ras 
family GTPase activation, some essential sites of RasGrf1 tyrosine phosphorylation for 
neurite outgrowth were also evaluated (Chapter 3). Using site directed mutagenesis 
targeting of several domains/sites of RasGrf1, a novel site of tyrosine phosphorylation 
was identified in the CDC25 domain. While 2 sites of Trk-induced tyrosine 
phosphorylation were identified in the PH1 and IQ domains of RasGrf1 (Tyr95 and 
Tyr233), these were not essential to support NGF-induced neurite outgrowth in PC12 cells. 
In instead, Tyrosine 1048 and/or tyrosine 1062 in the CDC25 domain appeared to be 
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crucial for RasGrf1 phosphorylation and to support neurotrophin-mediated neurite 
outgrowth. Further studies are required to understand whether one or both tyrosine sites 
are necessary for RasGrf1 tyrosine phosphorylation. Further study is also required to test 
other tyrosine sites within CDC25 domain and the Rac activation domain (DH domain) 
which might be involved in RasGrf1 tyrosine phosphorylation for neurotrophin-mediated 
neurite outgrowth. 
Collectively, our study focused on both NGF and BDNF-dependent RasGrf1 
enhancement of neurite outgrowth through specific Ras family GTPases to advance our 
understanding about a potential role for RasGrf1 in mediating Trk-dependent synaptic 
plasticity. Synaptic plasticity is regulated in part by NMDA receptors in the hippocampal 
area of brain, where BDNF-mediated TrkB receptor activation increases both presynaptic 
and postsynaptic transmission and regulates the activity of the NMDA-NR2B receptor 
(Levine and Kolb, 2000) although the mechanism of the coordination between two 
receptors and the downstream signalling pathways have not been fully understood. 
Consistent with the studies suggesting that BDNF increases phosphorylation of 
the NMDA receptor (Lin et al., 1998; Levine et al., 1998; Levine and Kolb, 2000), we 
have provided evidence showing that in cortical slices (Chapter 4), BDNF stimulation 
increases tyrosine1472 phosphorylation of the NR2B subunit of NMDA receptor, the site 
of which is crucial to retain NMDA receptors at the cell membrane (Nakazawa et al., 
2001; Prybylowski et al., 2005).  
On one hand, a direct interaction between the NR2B subunit and RasGrf1 has 
been observed in the presence of NMDA in both P30 cortical slices and TrkB-B5 cells 
(Robinson, 2008) which is in agreement with previous studies (Li et al., 2006; Kraivinsky 
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et al., 2003), and the level of interaction was reduced remarkably by addition of BDNF, 
suggesting that NMDA stimulation couples RasGrf1 to the NR2B subunit of the NMDA 
receptor while BDNF stimulation uncouples RasGrf1 from the NR2B subunit. On the 
other hand, a novel interaction was also observed between TrkB and RasGrf1 upon 
BDNF treatment in P30 cortical slices, which is consistent with similar observation in 
HEK293 cells (Robinson et al., 2005). Yet, no discernible detectable level of RasGrf1 
phosphorylation was observed in this interaction, suggesting that RasGrf1 either is not 
phosphorylated in vivo at all, opposite to what we have observed in vitro, or that the level 
of phosphorylation, or its relative stoichiometry, is lower than what we can detect with 
the currently available antibodies. Thus, to provide a more enriched lysate for the 
detection of RasGrf1 tyrosine-phosphorylation, a post synaptic density preparation is 
recommended for future studies. Altogether, these observations suggest that BDNF 
stimulation associates RasGrf1 with the Trk receptor while dissociating it from the NR2B 
subunit. BDNF stimulation increased tyrosine phosphorylation of the TrkB receptor on 
Tyr516, the site which is equivalent to Tyr499 on TrkA and serves as a docking site for the 
ShcC adaptor protein (Minichiello, 2009). This notion was further verified by a observing 
a direct interaction between TrkB and ShcC after BDNF stimulation with a loss of this 
interaction after NMDA stimulation (Robinson, 2008).  
The interaction between NR2B subunit and PSD-95 was also increased upon 
NMDA treatment (Robinson, 2008), and a loss of this interaction by the addition of 
BDNF was observed, similar to what was observed between the NR2B and RasGrf1, 
suggesting that RasGrf1 might be part of a complex with PSD95 intermediate signalling 
molecule. However, when RasGrf1 co-interaction with PSD95 intermediate signalling 
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proteins was tested, no interaction was detected between RasGrf1 and PSD95 under the 
condition in our study. Although it cannot be ruled out that there might be an interaction 
between RasGrf1 and PSD95 under other conditions such as in post-synaptic density 
preparation, which needs to be further addressed in future studies.  
To evaluate the activation of Erk/p38 MAP kinases downstream of RasGrf1, this 
study revealed that the phosphorylation of Erk MAP kinase was increased after 15 min 
BDNF treatment while NMDA treatment increased the phosphorylation of p38 MAP 
kinase. Although this observation is not in agreement with what was observed in the 
study by Krapivinsky et al., (2003), in which the interaction between RasGrf1-NR2B was 
associated with preferentially increased levels of Erk phosphoryation (Krapivinsky et al., 
2003), this result did agree with the study by Li et al., (2006). They showed that the 
interaction between RasGrf1 and the NR2B predominantely activated p38 MAP Kinase 
resulting in increases in long-term depression while the association of RasGrf2 with 
NR2A facilitates Erk activation with the result of promoting LTP ( Li et al., 2006). 
However, RasGrf1 and RasGrf2 may activate Erk through distinct pathways which need 
to be further investigated in future studies. Application of RasGrf1 and RasGrf2 knockout 
mice for the purpose of slice preparation could verify distinct roles of both RasGrf1 and 
RasGrf2 in the regulation of Erk activation in future studies. 
The coupling of NMDA receptor to Erk in the study by Krapivinsky et al., (2003) 
could be due to several reasons including whether the study had been performed in 
cultures or slices, the age of the mouse, and the specific region of the brain studied, all of 
which have been shown to affect the activation of signalling pathways downstream of the 
NMDA receptor (Tovar and Westbrook, 1999). Collectively this data suggests that 
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NMDA stimulation couples RasGrf1 to the NR2B subunit of the NMDA receptor to 
activate p38 MAP kinases while BDNF stimulation couples RasGrf1 to TrkB to activate 
Erk MAP kinases.  
To further verify RasGrf1-mediated coordination of Trk and NMDA receptors, it 
would be interesting to perform some inhibition experiments in future studies. For 
instance, since elevation in intracellular calcium promotes RasGrf1 activation as an 
intracellular calcium sensor, and it is involved in regulating the prolonged activation of 
the NMDA receptor, brain slices could be treated with an intracellular calcium chelator, 
BAPTA-AM, to determine if BDNF-induced RasGrf1 dissociation from the NR2B 
subunit of the NMDA receptor is affected, as well as whether BDNF/NMDA induces 
changes in Erk and/or p38 MAP kinase activation. Moreover, in this regard, the 
application of the NR2B inhibitor (Ifenprodil), Erk inhibition (by MEK inhibitor; U0126) 
or P38 inhibitor (SB230580) could also further clarify the changes in Erk or p38 MAP 
kinase activation in the RasGrf1-mediated coordination of Trk and NMDA receptor. 
To further address the role of RasGrf1 mediation of neurite outgrowth and neural 
plasticity, one of the most important regulators of RasGrf1 to study is Cyclin-dependent 
kinase 5, Cdk5. Cdk5 is a member of the cyclin-dependent kinase family. It is a proline-
directed serine/threonine kinase and crucial to the proper modulation of neurite formation 
and structure, neurite outgrowth and neuronal migration during brain development as 
well as learning and memory (Zhange et al., 2008). It has been shown that Cdk5 interacts 
with Trk and NMDA receptors as well as with RasGrf1. In fact, Cdk5 has been shown to 
phosphorylate RasGrf1 resulting in RasGrf1 degradation (Kesavapany et al., 2006). TrkB 
also interacts with Cdk5 as a substrate through which BDNF stimulation enhances Cdk5 
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activity resulting in dendritic growth (Cheung et al., 2007). In addition, Cdk5 regulates 
the activity of the NMDA receptor by decreasing NR2B phosphorylation and increasing 
receptor internalization (Zhange et al., 2008). How TrkB and NMDA receptors, as well 
as RasGrf1, may regulate Cdk5 activity and function is another question to be 
investigated in a future study. In this regard, brain slices can be treated with a Cdk5 
inhibitor, Roscovitine, before stimulation with BDNF/NMDA and assay changes in the 
level of RasGrf1 expression, its phosphorylation status, possible interaction with the 
TrkB/NR2B as well as changes in Erk/p38 MAP activities under these conditions. In 
addition, the localization study of RasGrf1 with either TrkB or the NR2B in specific 
regions of brain, such as postsynaptic density, may further clarify the nature of the 
signalling pattern down stream of both receptors.  
Using RasGrf1 knockout mice would also extensively clarify the RasGrf1 
modulation of TrkB-NR2B during neuronal growth and synaptic plasticity. RasGrf1 
knockout (-/-) mice exibit a severe deficit in amygdala-dependent synaptic plasticity with 
high synaptic activity in amygdala and hippocampal neurons (Brambilla et al., 1997), as 
well as impaired hippocampal-dependent plasticity evidenced as failures in performing 
hippocampal-dependent behavioral tests such as the Morris water maze, contextual 
discrimination and social transmission of food preferences (Giese et al., 2001). Thus, it 
would be interesting to perform hippocampal cell cultures from wild-type versus RasGrf1 
knockout mice to clarify whether BDNF-mediated Trk activation affects dendritic spine 
density, and whether NMDA-mediated NR2B activation are associated with a loss of 
dendritic spines. The activation of Rac and/or Ras-GTPases, as well as p38 and/or Erk-
MAP kinases downstream of RasGrf1 can also be compared in both wild type and 
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RasGrf1 knockout mice. This experiment can be examined either in intact cells or cells 
transfected with RasGrf1 plasmids, including RasGrf1-wild type, RasGrf1-DH domain 
mutant lacking binding site for Rac, and RasGrf1-CDC25 domain mutant lacking binding 
site for Ras. In this regard, as Post-natal day 3-5 is the optimum age in which RasGrf1 is 
expressed optimally, post-natal day 3-5 hippocampal cells from RasGrf1 knockout (-/-) 
and wild type mice could be cultured in the presence and absence of BDNF/NMDA, and 
dendrite spines assessed by immunohistochemically (IHC) using the dendritic spine 
marker, microtubule associated protein-2 (MAP-2), tubulin (axon marker), or Drebrin- an 
actin binding protein, and changes in cell morphology, including the length, count, size 
and intensity of dendrites could be determined statistically.  
Furthermore, a study by Li et al (2006) suggested that the interaction between 
RasGrf1 and NR2B specifically activated p38 MAP Kinase, but not Erk with increases in 
LTD while the association of RasGrf2 with NR2A facilitates Erk activation that results in 
the promotion of LTP.  However, RasGrf1 and RasGrf2 may activate Erk through distinct 
pathways which need to be further investigated in a future study. In this respect, slice 
preparations from RasGrf1 knockout mice could aid in verifying a distinct role for both 
RasGrf1 and RasGrf2 in Erk activation. 
Altogether, in this study two novel signalling pathways have been identified. 
First, that RasGrf1 facilitates neurotrophin-dependent neurite outgrowth via both Ras and 
Rac and that this requires tyrosine phosphorylation of RasGrf1 within the Cdc25 domain. 
Secondly, I have identified a mechanism whereby BDNF-mediated activation of TrkB 
may regulate the process of learning and memory. Specifically, within the mature brain I 
demonstrate that BDNF-mediated TrkB activation can modify NMDA receptor signalling 
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by specifically uncoupling RasGrf1 from NR2B while not affecting the association of 
RasGrf2 with NR2A. Since RasGrf1 signaling via NR2B is associated with LTP, this 
provides a potentially important mechanism by which TrkB may be facilitating the 
process of learning and memory. In addition to decreasing the potential of NMDA 
signaling to result in LTD, which may indirectly facilitate a potential increase in LTP, the 
potential for RasGrf1 to facilitate TrkB-mediated dendritic growth and spine formation 
may provide another means by which TrkB signaling may facilitate the process of 
learning and memory (see the proposed model in Figure 4-5). 
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